<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-03-11T00:59:12Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7806155" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7806155</identifier>
        <datestamp>2021-01-25</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-id journal-id-type="pmc">plosone</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7806155</article-id>
              <article-id pub-id-type="pmcid">PMC7806155</article-id>
              <article-id pub-id-type="pmc-uid">7806155</article-id>
              <article-id pub-id-type="pmid">33439880</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-20-13789</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0244474</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Infectious Diseases</subject>
                      <subj-group>
                        <subject>Viral Diseases</subject>
                        <subj-group>
                          <subject>Covid 19</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Diagnostic Medicine</subject>
                    <subj-group>
                      <subject>Virus Testing</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Physical Sciences</subject>
                  <subj-group>
                    <subject>Mathematics</subject>
                    <subj-group>
                      <subject>Applied Mathematics</subject>
                      <subj-group>
                        <subject>Algorithms</subject>
                        <subj-group>
                          <subject>Kalman Filter</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Research and Analysis Methods</subject>
                  <subj-group>
                    <subject>Simulation and Modeling</subject>
                    <subj-group>
                      <subject>Algorithms</subject>
                      <subj-group>
                        <subject>Kalman Filter</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>People and places</subject>
                  <subj-group>
                    <subject>Geographical locations</subject>
                    <subj-group>
                      <subject>Europe</subject>
                      <subj-group>
                        <subject>European Union</subject>
                        <subj-group>
                          <subject>Italy</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>People and Places</subject>
                  <subj-group>
                    <subject>Geographical Locations</subject>
                    <subj-group>
                      <subject>Europe</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Social Sciences</subject>
                  <subj-group>
                    <subject>Sociology</subject>
                    <subj-group>
                      <subject>Education</subject>
                      <subj-group>
                        <subject>School Closures</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                    <subj-group>
                      <subject>Pandemics</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>People and places</subject>
                  <subj-group>
                    <subject>Geographical locations</subject>
                    <subj-group>
                      <subject>Europe</subject>
                      <subj-group>
                        <subject>European Union</subject>
                        <subj-group>
                          <subject>Germany</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Tracking <inline-formula id="pone.0244474.e001"><alternatives><graphic xlink:href="pone.0244474.e001.jpg" id="pone.0244474.e001g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M1"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> of COVID-19: A new real-time estimation using the Kalman filter</article-title>
                <alt-title alt-title-type="running-head">Tracking <inline-formula id="pone.0244474.e002"><alternatives><graphic xlink:href="pone.0244474.e002.jpg" id="pone.0244474.e002g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M2"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> of COVID-19</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Arroyo-Marioli</surname>
                    <given-names>Francisco</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Software</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bullano</surname>
                    <given-names>Francisco</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Software</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4772-9424</contrib-id>
                  <name>
                    <surname>Kucinskas</surname>
                    <given-names>Simas</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Software</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="corresp" rid="cor001">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6469-0827</contrib-id>
                  <name>
                    <surname>Rondón-Moreno</surname>
                    <given-names>Carlos</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Software</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Central Bank of Chile, Santiago, Chile</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Humboldt University of Berlin, Berlin, Germany</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Sartorius</surname>
                    <given-names>Benn</given-names>
                  </name>
                  <role>Editor</role>
                  <xref ref-type="aff" rid="edit1"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>University of KwaZulu-Natal School of Social Sciences, SOUTH AFRICA</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>simas.kucinskas@hu-berlin.de</email></corresp>
              </author-notes>
              <pub-date pub-type="collection">
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>13</day>
                <month>1</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>13</day>
                <month>1</month>
                <year>2021</year>
              </pub-date>
              <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
              <volume>16</volume>
              <issue>1</issue>
              <elocation-id>e0244474</elocation-id>
              <history>
                <date date-type="received">
                  <day>10</day>
                  <month>5</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>11</day>
                  <month>12</month>
                  <year>2020</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2021 Arroyo-Marioli et al</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Arroyo-Marioli et al</copyright-holder>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0244474.pdf"/>
              <abstract>
                <p>We develop a new method for estimating the effective reproduction number of an infectious disease (<inline-formula id="pone.0244474.e003"><alternatives><graphic xlink:href="pone.0244474.e003.jpg" id="pone.0244474.e003g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M3"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula>) and apply it to track the dynamics of COVID-19. The method is based on the fact that in the SIR model, <inline-formula id="pone.0244474.e004"><alternatives><graphic xlink:href="pone.0244474.e004.jpg" id="pone.0244474.e004g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M4"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> is linearly related to the growth rate of the number of infected individuals. This time-varying growth rate is estimated using the Kalman filter from data on new cases. The method is easy to implement in standard statistical software, and it performs well even when the number of infected individuals is imperfectly measured, or the infection does not follow the SIR model. Our estimates of <inline-formula id="pone.0244474.e005"><alternatives><graphic xlink:href="pone.0244474.e005.jpg" id="pone.0244474.e005g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M5"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> for COVID-19 for 124 countries across the world are provided in an interactive <ext-link ext-link-type="uri" xlink:href="https://bit.ly/Rtlive">online dashboard</ext-link>, and they are used to assess the effectiveness of non-pharmaceutical interventions in a sample of 14 European countries.</p>
              </abstract>
              <funding-group>
                <funding-statement>The author(s) received no specific funding for this work.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="4"/>
                <table-count count="2"/>
                <page-count count="16"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>All relevant data are within the manuscript and its <xref ref-type="sec" rid="sec012">Supporting information</xref> files.</meta-value>
                </custom-meta>
                <custom-meta id="outbreaks">
                  <meta-name>Outbreaks</meta-name>
                  <meta-value>COVID-19</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>All relevant data are within the manuscript and its <xref ref-type="sec" rid="sec012">Supporting information</xref> files.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec001">
              <title>Introduction</title>
              <p>The effective reproduction number (<inline-formula id="pone.0244474.e006"><alternatives><graphic xlink:href="pone.0244474.e006.jpg" id="pone.0244474.e006g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M6"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula>) plays a central role in the epidemiology of infectious diseases. <inline-formula id="pone.0244474.e007"><alternatives><graphic xlink:href="pone.0244474.e007.jpg" id="pone.0244474.e007g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M7"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> is defined as the average number of secondary cases produced by a primary case [<xref rid="pone.0244474.ref001" ref-type="bibr">1</xref>–<xref rid="pone.0244474.ref003" ref-type="bibr">3</xref>]. The effective reproduction number varies over time, due to the depletion of susceptible individuals as well as changes in other factors, including control measures, contact rates, and climatic conditions. The <italic>basic reproduction number</italic>, denoted by <inline-formula id="pone.0244474.e008"><alternatives><graphic xlink:href="pone.0244474.e008.jpg" id="pone.0244474.e008g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M8"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>, measures the average number of secondary cases produced by a primary case when the population is fully susceptible [<xref rid="pone.0244474.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0244474.ref005" ref-type="bibr">5</xref>]. Analogously to the effective reproduction number, the basic reproduction number is also affected by multiple variables [<xref rid="pone.0244474.ref006" ref-type="bibr">6</xref>].</p>
              <p>In standard models, the number of infected individuals increases as long as <inline-formula id="pone.0244474.e009"><alternatives><graphic xlink:href="pone.0244474.e009.jpg" id="pone.0244474.e009g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M9"><mml:mrow><mml:mi mathvariant="script">R</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>. Real-time estimates of <inline-formula id="pone.0244474.e010"><alternatives><graphic xlink:href="pone.0244474.e010.jpg" id="pone.0244474.e010g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M10"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> are therefore essential for public policy decisions during a pandemic [<xref rid="pone.0244474.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0244474.ref008" ref-type="bibr">8</xref>]. Such estimates can be used to study the effectiveness of non-pharmaceutical interventions (NPIs), or assess what fraction of the population needs to be vaccinated to reach herd immunity [<xref rid="pone.0244474.ref009" ref-type="bibr">9</xref>–<xref rid="pone.0244474.ref011" ref-type="bibr">11</xref>]. Some social scientists have argued that <inline-formula id="pone.0244474.e011"><alternatives><graphic xlink:href="pone.0244474.e011.jpg" id="pone.0244474.e011g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M11"><mml:mrow><mml:mi mathvariant="script">R</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula> should be viewed as a fundamental constraint on public policy during the current COVID-19 pandemic [<xref rid="pone.0244474.ref012" ref-type="bibr">12</xref>].</p>
              <p>In this paper we develop a new method to estimate <inline-formula id="pone.0244474.e012"><alternatives><graphic xlink:href="pone.0244474.e012.jpg" id="pone.0244474.e012g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M12"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> in real time. The method exploits the fact that in the benchmark SIR model, <inline-formula id="pone.0244474.e013"><alternatives><graphic xlink:href="pone.0244474.e013.jpg" id="pone.0244474.e013g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M13"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> is linearly related to the growth rate of the number of infected individuals [<xref rid="pone.0244474.ref013" ref-type="bibr">13</xref>]. Our estimation procedure consists of three steps. First, we use data on new cases to construct a time series of how many individuals are infected at a given point in time. Then, we estimate the growth rate of this time series with the Kalman filter. In the final step, we leverage the theoretical relationship given by the SIR model to obtain <inline-formula id="pone.0244474.e014"><alternatives><graphic xlink:href="pone.0244474.e014.jpg" id="pone.0244474.e014g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M14"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> from the estimated growth rate. We show theoretically that the estimates are not sensitive to potential model misspecification, and they are fairly accurate even when new cases are imperfectly measured.</p>
              <p>We apply our methodology to estimate the <inline-formula id="pone.0244474.e015"><alternatives><graphic xlink:href="pone.0244474.e015.jpg" id="pone.0244474.e015g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M15"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> of COVID-19 in real-time. Our estimates for 124 countries across the world are provided in an online dashboard and can be explored interactively [<xref rid="pone.0244474.ref014" ref-type="bibr">14</xref>]. In empirical applications, we use these estimates to calculate the basic reproduction number (<inline-formula id="pone.0244474.e016"><alternatives><graphic xlink:href="pone.0244474.e016.jpg" id="pone.0244474.e016g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M16"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>) and evaluate the effects of NPIs in reducing <inline-formula id="pone.0244474.e017"><alternatives><graphic xlink:href="pone.0244474.e017.jpg" id="pone.0244474.e017g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M17"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> for a sample of 14 European countries.</p>
              <p>Under our baseline assumption that the serial interval for COVID-19 is seven days, we estimate the basic reproduction number (<inline-formula id="pone.0244474.e018"><alternatives><graphic xlink:href="pone.0244474.e018.jpg" id="pone.0244474.e018g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M18"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>) to be 2.66 (95% CI: 1.98–3.38). Next, we find that lockdowns, measures of self-isolation, and social distancing all have a statistically significant effect on reducing <inline-formula id="pone.0244474.e019"><alternatives><graphic xlink:href="pone.0244474.e019.jpg" id="pone.0244474.e019g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M19"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula>. However, we also demonstrate the importance of accounting for voluntary changes in behavior. In particular, we document that most of the decline in mobility in our sample happened before the introduction of lockdowns. Failing to account for voluntary changes in behavior leads to substantially over-estimated effects of NPIs.</p>
              <sec id="sec002">
                <title>Related literature</title>
                <p>There are two broad classes of methods that can be used to estimate <inline-formula id="pone.0244474.e020"><alternatives><graphic xlink:href="pone.0244474.e020.jpg" id="pone.0244474.e020g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M20"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> in real time [<xref rid="pone.0244474.ref002" ref-type="bibr">2</xref>, <xref rid="pone.0244474.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0244474.ref015" ref-type="bibr">15</xref>]. First, one can estimate a fully-specified epidemiological model and then construct a model-implied time series for <inline-formula id="pone.0244474.e021"><alternatives><graphic xlink:href="pone.0244474.e021.jpg" id="pone.0244474.e021g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M21"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> [<xref rid="pone.0244474.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0244474.ref016" ref-type="bibr">16</xref>–<xref rid="pone.0244474.ref018" ref-type="bibr">18</xref>]. Second, one may use approaches that leverage information on the serial interval of a disease (i.e., time between onset of symptoms in a case and onset of symptoms in his/her secondary cases) [<xref rid="pone.0244474.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0244474.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0244474.ref019" ref-type="bibr">19</xref>]. For example, imagine a disease with a fixed serial interval of, say, three days. In that case, we could estimate <inline-formula id="pone.0244474.e022"><alternatives><graphic xlink:href="pone.0244474.e022.jpg" id="pone.0244474.e022g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M22"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> by simply dividing the number of new cases today by the number of new cases three days ago. Cori et al [<xref rid="pone.0244474.ref003" ref-type="bibr">3</xref>] exploit this idea to develop a Bayesian estimator that accounts for the randomness in the onset of infections as well as variation in the serial interval. This method is implemented in a popular R package <monospace>EpiEstim</monospace> [<xref rid="pone.0244474.ref020" ref-type="bibr">20</xref>].</p>
                <p>The method proposed in this paper attempts to strike a balance between the two approaches mentioned above. Although our estimator is derived from standard epidemiological theory, we use the smallest amount of theoretical structure that is necessary to obtain our estimator. In particular, the theoretical relationship used to derive our estimator is exactly valid not only in the standard SIR model with constant parameters, but also in the SIS model and a generalized SIR model with time-varying parameters and stochastic shocks. Relative to the existing literature, our estimator does not need any statistical tuning parameters, and it does not require parametric assumptions on the distribution of new cases (such as assuming that new cases are Poisson distributed). For example, the method of Cori et al [<xref rid="pone.0244474.ref003" ref-type="bibr">3</xref>] assumes that <inline-formula id="pone.0244474.e023"><alternatives><graphic xlink:href="pone.0244474.e023.jpg" id="pone.0244474.e023g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M23"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> is constant over fixed windows of duration <italic>τ</italic>; <italic>τ</italic> effectively becomes a tuning parameter that needs to be chosen by the user. Our approach and its mathematical derivation share some similarities with the estimator proposed by Bettencourt and Ribeiro [<xref rid="pone.0244474.ref021" ref-type="bibr">21</xref>].</p>
                <p>A key advantage of using the Kalman filter for estimating <inline-formula id="pone.0244474.e024"><alternatives><graphic xlink:href="pone.0244474.e024.jpg" id="pone.0244474.e024g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M24"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> is that valid confidence bounds are readily obtained. Explicitly accounting for the dynamics in <inline-formula id="pone.0244474.e025"><alternatives><graphic xlink:href="pone.0244474.e025.jpg" id="pone.0244474.e025g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M25"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> via the state equation ensures that the estimated effective reproduction numbers are not excessively volatile, with the optimal amount of filtering estimated from the data. In addition, the Kalman smoother allows the researcher to use full-sample information efficiently when estimating <inline-formula id="pone.0244474.e026"><alternatives><graphic xlink:href="pone.0244474.e026.jpg" id="pone.0244474.e026g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M26"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula>. Finally, our method can be used with both classical and Bayesian techniques, as we demonstrate in the empirical application.</p>
              </sec>
            </sec>
            <sec sec-type="materials|methods" id="sec003">
              <title>Materials and methods</title>
              <sec id="sec004">
                <title>Data sources</title>
                <p>We use data on COVID-19 cases from the John Hopkins CSSE repository [<xref rid="pone.0244474.ref022" ref-type="bibr">22</xref>]. For some of our statistical analyses, we also use data on the number of daily tests per capita collected by <italic>Our World in Data</italic> [<xref rid="pone.0244474.ref023" ref-type="bibr">23</xref>], mobility data from Google’s “COVID-19 Community Mobility Reports” [<xref rid="pone.0244474.ref024" ref-type="bibr">24</xref>], and data on NPIs collected by Flaxman et al [<xref rid="pone.0244474.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0244474.ref026" ref-type="bibr">26</xref>]. All of these datasets are publicly available online. The computer code and data used in the study are provided in <xref ref-type="supplementary-material" rid="pone.0244474.s002">S1 File</xref>.</p>
              </sec>
              <sec id="sec005">
                <title>New real-time estimator</title>
                <p>We now derive our estimator for the SIR model [<xref rid="pone.0244474.ref013" ref-type="bibr">13</xref>]. In <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref> (Sections A.1 and A.2), we show that we can obtain the same estimator from an SIS model, and an SIR model with stochastic shocks.</p>
                <p>The standard SIR model in discrete time describes the evolution of susceptible (<italic>S</italic><sub><italic>t</italic></sub>), infected (<italic>I</italic><sub><italic>t</italic></sub>), and recovered (<italic>R</italic><sub><italic>t</italic></sub>) individuals by the following equations [<xref rid="pone.0244474.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0244474.ref028" ref-type="bibr">28</xref>]:
<disp-formula id="pone.0244474.e027"><alternatives><graphic xlink:href="pone.0244474.e027.jpg" id="pone.0244474.e027g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M27"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:msub><mml:mi>S</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfrac><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mi>N</mml:mi></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfrac><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mi>N</mml:mi></mml:mfrac><mml:mo>-</mml:mo><mml:mi>γ</mml:mi><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:msub><mml:mi>R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>γ</mml:mi><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(1)</label></disp-formula></p>
                <p>The model is stated at a daily frequency. Here, <italic>N</italic> ≡ <italic>S</italic><sub><italic>t</italic></sub> + <italic>I</italic><sub><italic>t</italic></sub> + <italic>R</italic><sub><italic>t</italic></sub> is the population size, <italic>β</italic><sub><italic>t</italic></sub> is the daily transmission rate, and <italic>γ</italic> is the daily transition rate from infected to recovered. The recovered group consists of individuals who have either died or fully recovered. We allow the transmission rate <italic>β</italic><sub><italic>t</italic></sub> to vary over time. For example, individuals may choose to to reduce their social interactions voluntarily, or they could be subject to government policy restrictions.</p>
                <p>The <italic>basic reproduction number</italic>, <inline-formula id="pone.0244474.e028"><alternatives><graphic xlink:href="pone.0244474.e028.jpg" id="pone.0244474.e028g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M28"><mml:msubsup><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>, is defined as <inline-formula id="pone.0244474.e029"><alternatives><graphic xlink:href="pone.0244474.e029.jpg" id="pone.0244474.e029g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M29"><mml:mrow><mml:msubsup><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup><mml:mo>≡</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>/</mml:mo><mml:mi>γ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>, and it gives the average number of individuals infected by a single infected individual when everyone else is susceptible. Since the transmission rate <italic>β</italic><sub><italic>t</italic></sub> varies over time, the basic reproduction number is generally time varying as well. The <italic>effective reproduction number</italic>, <inline-formula id="pone.0244474.e030"><alternatives><graphic xlink:href="pone.0244474.e030.jpg" id="pone.0244474.e030g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M30"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula>, is defined as <inline-formula id="pone.0244474.e031"><alternatives><graphic xlink:href="pone.0244474.e031.jpg" id="pone.0244474.e031g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M31"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:mi>N</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>, and it equals the average number of individuals infected by a single infected individual when a fraction (<italic>S</italic><sub><italic>t</italic>−1</sub>/<italic>N</italic>) of individuals is susceptible.</p>
                <p>From <xref ref-type="disp-formula" rid="pone.0244474.e027">Eq (1)</xref> the daily growth rate in the number of infected individuals is
<disp-formula id="pone.0244474.e032"><alternatives><graphic xlink:href="pone.0244474.e032.jpg" id="pone.0244474.e032g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M32"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mtext>gr</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>≡</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mfrac><mml:mo>=</mml:mo><mml:mi>γ</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(2)</label></disp-formula></p>
                <p>Denoting the estimated growth rate of infected individuals by <inline-formula id="pone.0244474.e033"><alternatives><graphic xlink:href="pone.0244474.e033.jpg" id="pone.0244474.e033g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M33"><mml:mrow><mml:mover accent="true"><mml:mtext>gr</mml:mtext><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>, and given a value for the transition rate <italic>γ</italic>, the plug-in estimator for the effective reproduction number is
<disp-formula id="pone.0244474.e034"><alternatives><graphic xlink:href="pone.0244474.e034.jpg" id="pone.0244474.e034g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M34"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi mathvariant="script">R</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>t</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>γ</mml:mi></mml:mfrac><mml:mover accent="true"><mml:mtext>gr</mml:mtext><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(3)</label></disp-formula></p>
                <p>For the estimator to be feasible, we need to (i) calibrate the transition rate from infectious to recovered, <italic>γ</italic>; and (ii) estimate the growth rate of <italic>I</italic><sub><italic>t</italic></sub>. There are two potential strategies for choosing <italic>γ</italic>. First, we can use external medical evidence given that <italic>γ</italic><sup>−1</sup> is the average infectious period. Second, information on the serial interval of the disease can be employed, given that the serial interval in the SIR model also equals <italic>γ</italic><sup>−1</sup> [<xref rid="pone.0244474.ref029" ref-type="bibr">29</xref>].</p>
                <p>To estimate the growth rate of <italic>I</italic><sub><italic>t</italic></sub> empirically, we first construct a time series for <italic>I</italic><sub><italic>t</italic></sub> from data on new cases. The SIR model in <xref ref-type="disp-formula" rid="pone.0244474.e027">Eq (1)</xref> implies that
<disp-formula id="pone.0244474.e035"><alternatives><graphic xlink:href="pone.0244474.e035.jpg" id="pone.0244474.e035g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M35"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>γ</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mtext>new</mml:mtext><mml:mspace width="4pt"/><mml:msub><mml:mtext>cases</mml:mtext><mml:mi>t</mml:mi></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(4)</label></disp-formula></p>
                <p>We initialize <italic>I</italic><sub><italic>t</italic></sub> by <italic>I</italic><sub>0</sub> = <italic>C</italic><sub>0</sub> where <italic>C</italic><sub>0</sub> is the total number of infectious cases at some initial date, and then construct subsequent values of <italic>I</italic><sub><italic>t</italic></sub> recursively.</p>
                <p>Given the time series for <italic>I</italic><sub><italic>t</italic></sub>, we use standard Kalman-filtering tools to smooth the observed growth rate of <italic>I</italic><sub><italic>t</italic></sub>. In particular, we specify the following state-space model for the growth rate of <italic>I</italic><sub><italic>t</italic></sub>:
<disp-formula id="pone.0244474.e036"><alternatives><graphic xlink:href="pone.0244474.e036.jpg" id="pone.0244474.e036g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M36"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mtext>gr</mml:mtext><mml:mo>(</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:mi>γ</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>ε</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mspace width="0.277778em"/><mml:mspace width="0.277778em"/><mml:msub><mml:mi>ε</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>∼</mml:mo><mml:mtext>i.i.d.</mml:mtext><mml:mspace width="4pt"/><mml:mi mathvariant="script">N</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>ε</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>η</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mspace width="0.277778em"/><mml:mspace width="0.277778em"/><mml:mspace width="0.277778em"/><mml:mspace width="0.277778em"/><mml:mspace width="0.277778em"/><mml:mspace width="12.37695pt"/><mml:msub><mml:mi>η</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>∼</mml:mo><mml:mtext>i.i.d.</mml:mtext><mml:mspace width="4pt"/><mml:mi mathvariant="script">N</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>η</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(5)</label></disp-formula></p>
                <p>We estimate <inline-formula id="pone.0244474.e037"><alternatives><graphic xlink:href="pone.0244474.e037.jpg" id="pone.0244474.e037g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M37"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> by the Kalman smoother [<xref rid="pone.0244474.ref030" ref-type="bibr">30</xref>]. The Kalman smoother provides optimal estimates of <inline-formula id="pone.0244474.e038"><alternatives><graphic xlink:href="pone.0244474.e038.jpg" id="pone.0244474.e038g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M38"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> (in the sense of minimizing mean-squared error) given the full-sample information on gr(<italic>I</italic><sub><italic>t</italic></sub>), provided that the data are generated by the model in <xref ref-type="disp-formula" rid="pone.0244474.e036">Eq (5)</xref>.</p>
                <p>To estimate the unknown parameters <inline-formula id="pone.0244474.e039"><alternatives><graphic xlink:href="pone.0244474.e039.jpg" id="pone.0244474.e039g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M39"><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>ε</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0244474.e040"><alternatives><graphic xlink:href="pone.0244474.e040.jpg" id="pone.0244474.e040g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M40"><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>η</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:math></alternatives></inline-formula> in <xref ref-type="disp-formula" rid="pone.0244474.e036">Eq (5)</xref>, both classical and Bayesian methods can be used. However, sample sizes are usually limited in practice, especially early on in the epidemic. Hence, incorporating prior knowledge generally leads to better-behaved estimates. The state-space model above—also known as the local-level model—can also be thought as a model-based version of exponentially-weighted moving-average smoothing [<xref rid="pone.0244474.ref031" ref-type="bibr">31</xref>].</p>
                <p>The state-space model in <xref ref-type="disp-formula" rid="pone.0244474.e036">Eq (5)</xref> can be viewed as a reduced-form time-series specification. The local-level model can capture fairly rich dynamic patterns in the data [<xref rid="pone.0244474.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0244474.ref032" ref-type="bibr">32</xref>]. In addition, in <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref> (Section A.3), we provide a theoretical rationale for the local-level specification. In particular, <xref ref-type="disp-formula" rid="pone.0244474.e036">Eq (5)</xref> arises naturally in the SIR model (in the early stages of an epidemic) when the transmission rate <italic>β</italic><sub><italic>t</italic></sub> follows a random walk.</p>
                <p>From <xref ref-type="disp-formula" rid="pone.0244474.e035">Eq (4)</xref>, the growth rate gr(<italic>I</italic><sub><italic>t</italic></sub>) is bounded below by (−<italic>γ</italic>). Hence, for any estimator of gr(<italic>I</italic><sub><italic>t</italic></sub>) that is some weighted average of the observed growth rates, the point estimate of <inline-formula id="pone.0244474.e041"><alternatives><graphic xlink:href="pone.0244474.e041.jpg" id="pone.0244474.e041g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M41"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> is automatically non-negative. To ensure that lower confidence bounds are positive as well, we estimate the <italic>q</italic>-th quantile of <inline-formula id="pone.0244474.e042"><alternatives><graphic xlink:href="pone.0244474.e042.jpg" id="pone.0244474.e042g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M42"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> by <inline-formula id="pone.0244474.e043"><alternatives><graphic xlink:href="pone.0244474.e043.jpg" id="pone.0244474.e043g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M43"><mml:mrow><mml:mo form="prefix" movablelimits="true">max</mml:mo><mml:mo>{</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mi>γ</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:msub><mml:mover accent="true"><mml:mi>g</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>q</mml:mi></mml:msub><mml:mo>}</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>, where <inline-formula id="pone.0244474.e044"><alternatives><graphic xlink:href="pone.0244474.e044.jpg" id="pone.0244474.e044g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M44"><mml:msub><mml:mover accent="true"><mml:mi>g</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>q</mml:mi></mml:msub></mml:math></alternatives></inline-formula> is an estimate of the <italic>q</italic>-th quantile of gr(<italic>I</italic><sub><italic>t</italic></sub>). In addition (see Section A.4 in <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref>), our empirical estimates remain similar when we use a modified version of the Carter-Kohn [<xref rid="pone.0244474.ref033" ref-type="bibr">33</xref>] algorithm which discards random draws violating the non-negativity constraint. Alternatively, it is possible to avoid this type of truncation by using non-linear filtering methods [<xref rid="pone.0244474.ref034" ref-type="bibr">34</xref>].</p>
              </sec>
              <sec id="sec006">
                <title>Sensitivity to model misspecification and data problems</title>
                <p>Tracking the evolution of <inline-formula id="pone.0244474.e045"><alternatives><graphic xlink:href="pone.0244474.e045.jpg" id="pone.0244474.e045g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M45"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> is notoriously difficult. Human-contact dynamics, testing, and changes in case definitions affect the flow and quality of the available information. In this section, we test the sensitivity of our estimator to two notable issues: (i) model misspecification; and (ii) data problems (such as reporting delays or imperfect detection of infectious individuals).</p>
                <p>For the first issue, model misspecification, a natural concern is whether the true dynamics of the disease are well captured by the benchmark SIR model. We address this issue in two ways. First, we show that our estimator remains exactly valid in the SIS model in which individuals do not obtain immunity, and a generalized SIR model with stochastic shocks (see Sections A.1 and A.2 in <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref>). In addition, provided that the average duration of infectiousness is correctly specified, we find that our estimator yields accurate results even when the true model is SEIR rather than SIR (see Section A.5 in <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref>). Second, we note that the error term <italic>ε</italic><sub><italic>t</italic></sub> in the state-space model described by <xref ref-type="disp-formula" rid="pone.0244474.e036">Eq (5)</xref> can be interpreted as model error. Therefore, our estimates as well as their confidence intervals explicitly account for (some amount of) potential misspecification.</p>
                <p>The second issue relates to data reliability. For COVID-19, testing constraints and high asymptomatic prevalence [<xref rid="pone.0244474.ref035" ref-type="bibr">35</xref>–<xref rid="pone.0244474.ref037" ref-type="bibr">37</xref>], in particular, make it challenging to identify all infectious individuals. The simplicity of our estimator allows us to analytically characterize the effects of potential measurement error (see Section A.6 in <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref>). Furthermore, we use these results to investigate the quantitative performance of the estimator in a number of empirically relevant underdetection scenarios using Monte Carlo simulations. Overall, we conclude that our method provides accurate estimates in all cases that we analyze.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec007">
              <title>Results</title>
              <p>In our estimations, we include all countries for which we have at least 20 daily observations after the cumulative number of confirmed COVID-19 cases reaches 100. Our sample period starts on 2020-01-23 and finishes on 2020-05-06. For the baseline estimates, we assume that people are infectious for <italic>γ</italic><sup>−1</sup> = 7 days on average, consistent with recent literature [<xref rid="pone.0244474.ref038" ref-type="bibr">38</xref>, <xref rid="pone.0244474.ref039" ref-type="bibr">39</xref>]. This assumption also accords with the evidence on the serial interval of COVID-19. For example, Flaxman et al [<xref rid="pone.0244474.ref025" ref-type="bibr">25</xref>] use an average serial interval of 6.5 days. Recent studies find that estimates of the serial interval for COVID-19 generally range between 4 and 9 days [<xref rid="pone.0244474.ref040" ref-type="bibr">40</xref>–<xref rid="pone.0244474.ref042" ref-type="bibr">42</xref>]. In addition, we document that <italic>γ</italic><sup>−1</sup> = 7 leads to estimates of the basic reproduction number (<inline-formula id="pone.0244474.e046"><alternatives><graphic xlink:href="pone.0244474.e046.jpg" id="pone.0244474.e046g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M46"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>) that are in line with the recent estimates in the literature [<xref rid="pone.0244474.ref043" ref-type="bibr">43</xref>]. However, we also investigate the effects of different choices for <italic>γ</italic> on our results. In general, by virtue of <xref ref-type="disp-formula" rid="pone.0244474.e034">Eq (3)</xref>, changing <italic>γ</italic> tilts the estimates of <inline-formula id="pone.0244474.e047"><alternatives><graphic xlink:href="pone.0244474.e047.jpg" id="pone.0244474.e047g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M47"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> around one, with higher values of the serial interval pushing the estimates away from one and lower values pushing the estimates towards one. For example, if <inline-formula id="pone.0244474.e048"><alternatives><graphic xlink:href="pone.0244474.e048.jpg" id="pone.0244474.e048g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M48"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi mathvariant="script">R</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>t</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>.</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula> for <italic>γ</italic><sup>−1</sup> = 7 days, increasing the serial interval to 8 days increases the estimate to <inline-formula id="pone.0244474.e049"><alternatives><graphic xlink:href="pone.0244474.e049.jpg" id="pone.0244474.e049g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M49"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi mathvariant="script">R</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>t</mml:mi></mml:msub><mml:mo>≈</mml:mo><mml:mn>1</mml:mn><mml:mo>.</mml:mo><mml:mn>57</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>. Conversely, if <inline-formula id="pone.0244474.e050"><alternatives><graphic xlink:href="pone.0244474.e050.jpg" id="pone.0244474.e050g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M50"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi mathvariant="script">R</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>t</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula> for <italic>γ</italic><sup>−1</sup> = 7 days, increasing the serial interval to 8 days decreases the estimate to <inline-formula id="pone.0244474.e051"><alternatives><graphic xlink:href="pone.0244474.e051.jpg" id="pone.0244474.e051g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M51"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi mathvariant="script">R</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>t</mml:mi></mml:msub><mml:mo>≈</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>43</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>. <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref> (Section A.7) describes the details of the estimation procedure. <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref> (Section A.15) also contains the GATHER checklist [<xref rid="pone.0244474.ref044" ref-type="bibr">44</xref>], summarizing the details of the analysis.</p>
              <p>In <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref> (Section A.8), we perform two empirical validation exercises of our estimates. First, we document that our estimates of <inline-formula id="pone.0244474.e052"><alternatives><graphic xlink:href="pone.0244474.e052.jpg" id="pone.0244474.e052g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M52"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> are predictive of future deaths. Given that deaths are arguably more accurately measured, this finding alleviates concerns regarding potential data reliability issues that could contaminate our estimates. Second, we find that past mobility data is predictive of future values of <inline-formula id="pone.0244474.e053"><alternatives><graphic xlink:href="pone.0244474.e053.jpg" id="pone.0244474.e053g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M53"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula>. In <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref> (Section A.12), we additionally compare our estimates to those obtained using the method of Cori et al [<xref rid="pone.0244474.ref003" ref-type="bibr">3</xref>]. We find that our estimates are highly correlated to the estimates produced by the Cori et al method, with the average correlation coefficient across different countries equal to 0.80 (median: 0.89). Jointly, these exercises suggest that our estimates contain valuable information on the dynamics of COVID-19.</p>
              <sec id="sec008">
                <title>Estimated effective reproduction numbers</title>
                <p>Our estimates of <inline-formula id="pone.0244474.e054"><alternatives><graphic xlink:href="pone.0244474.e054.jpg" id="pone.0244474.e054g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M54"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> for selected countries are shown in Figs <xref ref-type="fig" rid="pone.0244474.g001">1</xref> and <xref ref-type="fig" rid="pone.0244474.g002">2</xref>. Estimates for the remaining countries can be found in the associated dashboard [<xref rid="pone.0244474.ref014" ref-type="bibr">14</xref>].</p>
                <fig id="pone.0244474.g001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0244474.g001</object-id>
                  <label>Fig 1</label>
                  <caption>
                    <title><inline-formula id="pone.0244474.e055"><alternatives><graphic id="pone.0244474.e055g" xlink:href="pone.0244474.e055"/><mml:math id="M55"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> of COVID-19: China, Italy, and the US.</title>
                    <p>Estimates of the effective reproduction rate (<inline-formula id="pone.0244474.e056"><alternatives><graphic id="pone.0244474.e056g" xlink:href="pone.0244474.e056"/><mml:math id="M56"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula>) of COVID-19 for selected countries. The sample consists of all dates after the total number of reported cases in the country has reached 100. 65% credible bounds shown by the shaded areas.</p>
                  </caption>
                  <graphic xlink:href="pone.0244474.g001"/>
                </fig>
                <fig id="pone.0244474.g002" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0244474.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title><inline-formula id="pone.0244474.e057"><alternatives><graphic id="pone.0244474.e057g" xlink:href="pone.0244474.e057"/><mml:math id="M57"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> of COVID-19: Brazil, India, and Germany.</title>
                    <p>Estimates of the effective reproduction rate (<inline-formula id="pone.0244474.e058"><alternatives><graphic id="pone.0244474.e058g" xlink:href="pone.0244474.e058"/><mml:math id="M58"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula>) of COVID-19 for selected countries. The sample consists of all dates after the total number of reported cases in the country has reached 100. 65% credible bounds shown by the shaded areas.</p>
                  </caption>
                  <graphic xlink:href="pone.0244474.g002"/>
                </fig>
                <p><xref ref-type="fig" rid="pone.0244474.g001">Fig 1</xref> plots the estimated effective reproduction numbers for China, Italy, and the US. In <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref> (Section A.9, Fig A.7), we also provide a graph of the raw data on the growth rate of the number of infected individuals that is used for estimating <inline-formula id="pone.0244474.e059"><alternatives><graphic xlink:href="pone.0244474.e059.jpg" id="pone.0244474.e059g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M59"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula>. For all three countries, the estimated <inline-formula id="pone.0244474.e060"><alternatives><graphic xlink:href="pone.0244474.e060.jpg" id="pone.0244474.e060g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M60"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> is initially above 3. For China, the estimated <inline-formula id="pone.0244474.e061"><alternatives><graphic xlink:href="pone.0244474.e061.jpg" id="pone.0244474.e061g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M61"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> declined rapidly, falling below one around the third week of February. According to our estimates, <inline-formula id="pone.0244474.e062"><alternatives><graphic xlink:href="pone.0244474.e062.jpg" id="pone.0244474.e062g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M62"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> in China fell below one 24 days after the beginning of the epidemic in the country (with the start of the epidemic defined as reaching 100 cumulative confirmed cases of COVID-19). However, the estimated <inline-formula id="pone.0244474.e063"><alternatives><graphic xlink:href="pone.0244474.e063.jpg" id="pone.0244474.e063g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M63"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> in China drifted up towards one during late March and early April, potentially caused by a wave of imported cases. Note that there is an upwards jump in the estimated <inline-formula id="pone.0244474.e064"><alternatives><graphic xlink:href="pone.0244474.e064.jpg" id="pone.0244474.e064g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M64"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> for China around the second week of February. This jump was caused by a temporary change in COVID-19 case definitions in the Hubei province in China; the new definition included clinically-diagnosed COVID-19 cases [<xref rid="pone.0244474.ref045" ref-type="bibr">45</xref>].</p>
                <p>In Italy, the estimated <inline-formula id="pone.0244474.e065"><alternatives><graphic xlink:href="pone.0244474.e065.jpg" id="pone.0244474.e065g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M65"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> fell steadily since March but at a slower rate than previously observed in China, with the point estimate for Italy falling below one in early April. Our estimates indicate that it took 36 days for <inline-formula id="pone.0244474.e066"><alternatives><graphic xlink:href="pone.0244474.e066.jpg" id="pone.0244474.e066g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M66"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> to fall below one after the start of the epidemic in Italy. In the US, the point estimates of <inline-formula id="pone.0244474.e067"><alternatives><graphic xlink:href="pone.0244474.e067.jpg" id="pone.0244474.e067g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M67"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> were fairly flat in the first two weeks of the epidemic, hovering around 3.5. We note, however, that it is likely that the fraction of non-detected cases in the US went down substantially in this period, inflating the estimates of <inline-formula id="pone.0244474.e068"><alternatives><graphic xlink:href="pone.0244474.e068.jpg" id="pone.0244474.e068g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M68"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> upward. In particular, the daily number of tests conducted in the U.S went up dramatically during this period, increasing by a factor of 45 between March 8, 2020 and March 25, 2020 [<xref rid="pone.0244474.ref023" ref-type="bibr">23</xref>]. It took 52 days for the estimated <inline-formula id="pone.0244474.e069"><alternatives><graphic xlink:href="pone.0244474.e069.jpg" id="pone.0244474.e069g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M69"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> to fall below one for the first time in the US after the start of the epidemic, or more than twice as long as in China. The point estimate of <inline-formula id="pone.0244474.e070"><alternatives><graphic xlink:href="pone.0244474.e070.jpg" id="pone.0244474.e070g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M70"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> in the US at the end of the sample is below one and equal to 0.92 (95% CI: 0.17–1.66).</p>
                <p><xref ref-type="fig" rid="pone.0244474.g002">Fig 2</xref> plots the estimated effective reproduction numbers for Brazil, India, and Germany. The pattern observed in Germany is similar to that previously seen in Italy and the United States. The estimated <inline-formula id="pone.0244474.e071"><alternatives><graphic xlink:href="pone.0244474.e071.jpg" id="pone.0244474.e071g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M71"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> in Germany falls below one 37 days after the beginning of the pandemic, almost identically to Italy. In Brazil and India, the point estimates of <inline-formula id="pone.0244474.e072"><alternatives><graphic xlink:href="pone.0244474.e072.jpg" id="pone.0244474.e072g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M72"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> are lower at the beginning of the pandemic than in the other countries plotted here. The effective reproduction numbers at the beginning of the epidemic are estimated to be 2.13 (95% CI: 0.81–3.04) in Brazil, and 1.78 (95% CI: 0.92–2.41) in India. In contrast, for example, <inline-formula id="pone.0244474.e073"><alternatives><graphic xlink:href="pone.0244474.e073.jpg" id="pone.0244474.e073g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M73"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> is estimated to be 2.86 (95% CI: 1.91–3.81) in Germany at the beginning of the pandemic. We emphasize that the estimated confidence bounds are wide, indicating substantial uncertainty about the true values of <inline-formula id="pone.0244474.e074"><alternatives><graphic xlink:href="pone.0244474.e074.jpg" id="pone.0244474.e074g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M74"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula>. Hence, substantial caution must be exercised when comparing the estimates of <inline-formula id="pone.0244474.e075"><alternatives><graphic xlink:href="pone.0244474.e075.jpg" id="pone.0244474.e075g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M75"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> across countries and over time.</p>
                <p>A natural concern with any estimator of <inline-formula id="pone.0244474.e076"><alternatives><graphic xlink:href="pone.0244474.e076.jpg" id="pone.0244474.e076g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M76"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> applied to COVID-19 is that the estimator may be biased if only a fraction of all COVID-19 cases is detected. In <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref> (Section A.6), we study the performance of our estimator under various assumptions on the reporting of COVID-19 cases. We show analytically that our estimator remains exactly valid even when only a fraction of all cases is detected (e.g., 10% of all cases are detected), provided that the fraction of all cases detected is constant over time. The estimates are also accurate under some other cases of misreporting. However, if the fraction of detected COVID-19 cases changes a lot over short windows of time, the estimator is biased. Finally, we investigate the performance of our estimator in a number of additional cases of imperfect reporting (such as a ramp-up in testing) that may be important in practice using Monte Carlo simulations. Overall, we conclude that our estimator is robust to potential mismeasurement of COVID-19 cases in a number of empirically-relevant scenarios.</p>
                <p>In <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref> (Section A.10, Fig A.8), we illustrate the difference between estimates of <inline-formula id="pone.0244474.e077"><alternatives><graphic xlink:href="pone.0244474.e077.jpg" id="pone.0244474.e077g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M77"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> for China obtained by the Kalman smoother—as in our baseline estimation—and the Kalman filter. Intuitively, the Kalman smoother uses information from the full sample when estimating <inline-formula id="pone.0244474.e078"><alternatives><graphic xlink:href="pone.0244474.e078.jpg" id="pone.0244474.e078g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M78"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula>, while the Kalman filter only uses information up to and including time <italic>t</italic> [<xref rid="pone.0244474.ref030" ref-type="bibr">30</xref>]. While the two sets of estimates are fairly similar, the filtered estimates are substantially more volatile. In addition, the filtered estimates generally have wider credible bounds. As should be the case, the filtered and smoothed estimates are identical at the endpoint of the sample. From the perspective of epidemiological theory, the Kalman filter essentially produces what Fraser [<xref rid="pone.0244474.ref046" ref-type="bibr">46</xref>] refers to as the instantaneous reproduction number, while the Kalman smoother yields the case reproduction number. The estimator proposed in the present paper therefore allows researchers to estimate the two types of reproduction numbers in a single unified framework.</p>
                <p>In <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref> (Section A.10, Fig A.8), we also demonstrate the difference between our Bayesian estimates of <inline-formula id="pone.0244474.e079"><alternatives><graphic xlink:href="pone.0244474.e079.jpg" id="pone.0244474.e079g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M79"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> and classical estimates obtained via maximum likelihood. For China, the two sets of estimates are virtually indistinguishable, indicating that the chosen priors have a small effect on the estimates. Of course, for other some countries in our sample, the data are less informative, and hence the priors have a more pronounced effect.</p>
              </sec>
              <sec id="sec009">
                <title>Basic reproduction number</title>
                <p>We now use our estimates of <inline-formula id="pone.0244474.e080"><alternatives><graphic xlink:href="pone.0244474.e080.jpg" id="pone.0244474.e080g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M80"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> to measure the basic reproduction number (<inline-formula id="pone.0244474.e081"><alternatives><graphic xlink:href="pone.0244474.e081.jpg" id="pone.0244474.e081g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M81"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>), i.e., the average number of individuals infected by a single infectious individual when the population is fully susceptible. We estimate <inline-formula id="pone.0244474.e082"><alternatives><graphic xlink:href="pone.0244474.e082.jpg" id="pone.0244474.e082g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M82"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula> by the average value of <inline-formula id="pone.0244474.e083"><alternatives><graphic xlink:href="pone.0244474.e083.jpg" id="pone.0244474.e083g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M83"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> in the first week of the epidemic.</p>
                <p><xref rid="pone.0244474.t001" ref-type="table">Table 1</xref> shows the results for a sample of 14 European countries (Austria, Belgium, Denmark, France, Germany, Greece, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and United Kingdom), as in Flaxman et al [<xref rid="pone.0244474.ref025" ref-type="bibr">25</xref>]. Under our baseline assumption that the individuals are infectious for 7 days on average (<italic>γ</italic> = 1/7), we obtain an estimate of <inline-formula id="pone.0244474.e084"><alternatives><graphic xlink:href="pone.0244474.e084.jpg" id="pone.0244474.e084g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M84"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mo>.</mml:mo><mml:mn>66</mml:mn></mml:mrow></mml:math></alternatives></inline-formula> (95% CI: 1.98–3.38). For COVID-19, a recent meta-study has estimated a median <inline-formula id="pone.0244474.e085"><alternatives><graphic xlink:href="pone.0244474.e085.jpg" id="pone.0244474.e085g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M85"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula> of 2.79 [<xref rid="pone.0244474.ref043" ref-type="bibr">43</xref>], suggesting that our results are consistent with the current consensus estimates.</p>
                <table-wrap id="pone.0244474.t001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0244474.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>Estimates of the basic reproduction number (<inline-formula id="pone.0244474.e086"><alternatives><graphic id="pone.0244474.e086g" xlink:href="pone.0244474.e086"/><mml:math id="M86"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>).</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0244474.t001g" xlink:href="pone.0244474.t001"/>
                    <table frame="box" rules="all" border="0">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Number of Days Infectious:</th>
                          <th align="center" rowspan="1" colspan="1">5</th>
                          <th align="center" rowspan="1" colspan="1">6</th>
                          <th align="center" rowspan="1" colspan="1">7</th>
                          <th align="center" rowspan="1" colspan="1">8</th>
                          <th align="center" rowspan="1" colspan="1">9</th>
                          <th align="center" rowspan="1" colspan="1">10</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <inline-formula id="pone.0244474.e087">
                              <alternatives>
                                <graphic id="pone.0244474.e087g" xlink:href="pone.0244474.e087"/>
                                <mml:math id="M87">
                                  <mml:msub>
                                    <mml:mover accent="true">
                                      <mml:mi mathvariant="script">R</mml:mi>
                                      <mml:mo>^</mml:mo>
                                    </mml:mover>
                                    <mml:mn>0</mml:mn>
                                  </mml:msub>
                                </mml:math>
                              </alternatives>
                            </inline-formula>
                          </td>
                          <td align="char" char="." rowspan="1" colspan="1">2.07</td>
                          <td align="char" char="." rowspan="1" colspan="1">2.35</td>
                          <td align="char" char="." rowspan="1" colspan="1">2.66</td>
                          <td align="char" char="." rowspan="1" colspan="1">2.89</td>
                          <td align="char" char="." rowspan="1" colspan="1">3.10</td>
                          <td align="char" char="." rowspan="1" colspan="1">3.29</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CI Lower Bound (95%)</td>
                          <td align="char" char="." rowspan="1" colspan="1">1.51</td>
                          <td align="char" char="." rowspan="1" colspan="1">1.75</td>
                          <td align="char" char="." rowspan="1" colspan="1">1.98</td>
                          <td align="char" char="." rowspan="1" colspan="1">2.17</td>
                          <td align="char" char="." rowspan="1" colspan="1">2.37</td>
                          <td align="char" char="." rowspan="1" colspan="1">2.54</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CI Upper Bound (95%)</td>
                          <td align="char" char="." rowspan="1" colspan="1">2.67</td>
                          <td align="char" char="." rowspan="1" colspan="1">3.01</td>
                          <td align="char" char="." rowspan="1" colspan="1">3.38</td>
                          <td align="char" char="." rowspan="1" colspan="1">3.67</td>
                          <td align="char" char="." rowspan="1" colspan="1">3.86</td>
                          <td align="char" char="." rowspan="1" colspan="1">4.06</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t001fn001">
                      <p>Estimates of the basic reproduction number (<inline-formula id="pone.0244474.e088"><alternatives><graphic id="pone.0244474.e088g" xlink:href="pone.0244474.e088"/><mml:math id="M88"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>) for a sample of 14 European countries. The countries included in the sample are Austria, Belgium, Denmark, France, Germany, Greece, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and United Kingdom. The basic reproduction number is calculated by averaging our estimates of the effective reproduction number in the first 7 days of the epidemic, where the start of the epidemic is defined as the day when the cumulative number of cases reaches 100.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p><xref rid="pone.0244474.t001" ref-type="table">Table 1</xref> also provides the estimated <inline-formula id="pone.0244474.e089"><alternatives><graphic xlink:href="pone.0244474.e089.jpg" id="pone.0244474.e089g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M89"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula> under different assumptions on the duration of infectiousness (or, equivalently in the SIR model, the average serial interval). As expected, the median estimate is sensitive to the choice of <italic>γ</italic>; we find an additional day of infectiousness increases <inline-formula id="pone.0244474.e090"><alternatives><graphic xlink:href="pone.0244474.e090.jpg" id="pone.0244474.e090g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M90"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula> by around 0.3.</p>
              </sec>
              <sec id="sec010">
                <title>Assessing non-pharmaceutical interventions</title>
                <p>Finally, we use our estimates to assess the effects of non-pharmaceutical interventions (NPIs) in the same sample of 14 European countries as in the previous section. We study a total of five NPIs: (i) lockdowns; (ii) bans of public events; (iii) school closures; (iv) mandated self-isolation when exhibiting symptoms; and (e) social distancing measures. We adopt the definitions of NPIs and their introduction dates provided by Flaxman et al [<xref rid="pone.0244474.ref025" ref-type="bibr">25</xref>].</p>
                <p>We first perform an event-study exercise, inspired by event studies commonly used in economics and finance [<xref rid="pone.0244474.ref047" ref-type="bibr">47</xref>]. In this exercise, we compare the dynamics of the effective reproduction number before and after the introduction of a particular control measure. If the control measure is effective, we expect to observe a difference in the behavior of <inline-formula id="pone.0244474.e091"><alternatives><graphic xlink:href="pone.0244474.e091.jpg" id="pone.0244474.e091g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M91"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> after its introduction. The difference may appear as either a change in levels (“jump”) or a change in trends (“kink”); the latter possibility is more likely in the present empirical context. This simple before-versus-after comparison is not free of potential bias. In particular, the comparison implicitly assumes that the behavior of <inline-formula id="pone.0244474.e092"><alternatives><graphic xlink:href="pone.0244474.e092.jpg" id="pone.0244474.e092g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M92"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> before the intervention provides a good counterfactual for the (unobserved) future behavior of <inline-formula id="pone.0244474.e093"><alternatives><graphic xlink:href="pone.0244474.e093.jpg" id="pone.0244474.e093g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M93"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> in the absence of the intervention. Nevertheless, we find this exercise instructive as a preliminary step in our analysis.</p>
                <p><xref ref-type="fig" rid="pone.0244474.g003">Fig 3</xref> plots the estimated values of <inline-formula id="pone.0244474.e094"><alternatives><graphic xlink:href="pone.0244474.e094.jpg" id="pone.0244474.e094g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M94"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> one week before and three weeks after the introduction of a lockdown. Since Sweden did not have a lockdown in the sample period considered, the figure is constructed using data from 13 countries. <inline-formula id="pone.0244474.e095"><alternatives><graphic xlink:href="pone.0244474.e095.jpg" id="pone.0244474.e095g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M95"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> declines substantially after a lockdown is introduced, going from 2.11 (95% CI: 1.84–2.38) on the day of the intervention to 0.99 (95% CI: 0.87–1.11) three weeks later. However, <inline-formula id="pone.0244474.e096"><alternatives><graphic xlink:href="pone.0244474.e096.jpg" id="pone.0244474.e096g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M96"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> is decreasing before the lockdown as well. In particular, there is no visually detectible break in the slope of <inline-formula id="pone.0244474.e097"><alternatives><graphic xlink:href="pone.0244474.e097.jpg" id="pone.0244474.e097g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M97"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> in the three-week period after the introduction of the lockdown (i.e., no “kink”). In <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref> (Section A.13, Fig A.10 to Fig A.13), we show that other NPIs follow a similar pattern. In particular, we document the behavior of <inline-formula id="pone.0244474.e098"><alternatives><graphic xlink:href="pone.0244474.e098.jpg" id="pone.0244474.e098g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M98"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> around the introduction of public-event bans, case-based measures (such as self-isolation whenever feeling ill and experiencing fever), school closures, and social-distancing measures. Except for school closures and public-event bans, there is no visually apparent break in the trend of <inline-formula id="pone.0244474.e099"><alternatives><graphic xlink:href="pone.0244474.e099.jpg" id="pone.0244474.e099g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M99"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> around the date of the policy intervention.</p>
                <fig id="pone.0244474.g003" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0244474.g003</object-id>
                  <label>Fig 3</label>
                  <caption>
                    <title><inline-formula id="pone.0244474.e100"><alternatives><graphic id="pone.0244474.e100g" xlink:href="pone.0244474.e100"/><mml:math id="M100"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> and policy interventions: Lockdowns.</title>
                    <p>Estimated effective reproduction number (<inline-formula id="pone.0244474.e101"><alternatives><graphic id="pone.0244474.e101g" xlink:href="pone.0244474.e101"/><mml:math id="M101"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula>) one week before and three weeks after a lockdown is introduced in a country. The original sample consists of 14 European countries studied by Flaxman et al [<xref rid="pone.0244474.ref025" ref-type="bibr">25</xref>]. Heteroskedasticity-robust confidence bounds are shown by the shaded areas.</p>
                  </caption>
                  <graphic xlink:href="pone.0244474.g003"/>
                </fig>
                <p>To further investigate the behavior of <inline-formula id="pone.0244474.e102"><alternatives><graphic xlink:href="pone.0244474.e102.jpg" id="pone.0244474.e102g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M102"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> in the four-week window around lockdowns, we use mobility data from Google’s “COVID-19 Community Mobility Reports” [<xref rid="pone.0244474.ref024" ref-type="bibr">24</xref>]. Google uses smartphone location data to measure changes in mobility (relative to pre-pandemic levels) for six six types of places: (i) groceries and pharmacies; (ii) parks; (iii) transit stations; (iv) retail and recreation; (v) residential; and (vi) workplaces. Since these measures are strongly correlated, we take the first principal component of the six time series to construct an overall mobility index. The first principal component explains 83.03% of the total variation in Google’s mobility data.</p>
                <p><xref ref-type="fig" rid="pone.0244474.g004">Fig 4</xref> shows that most of the decline in mobility occurs <italic>before</italic> the imposition of the lockdown, and remains low <italic>thereafter</italic>. This finding shows a clear change in people’s behavior in the early days of the pandemic. Shifting habits before the introduction of NPIs is consistent with the existence of private motives that can induce a reduction in mobility as people avoid becoming infected [<xref rid="pone.0244474.ref048" ref-type="bibr">48</xref>–<xref rid="pone.0244474.ref050" ref-type="bibr">50</xref>]. Our results are also consistent with empirical evidence for the U.S and anecdotal reports from Sweden [<xref rid="pone.0244474.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0244474.ref051" ref-type="bibr">51</xref>]. The documented relationship between <inline-formula id="pone.0244474.e103"><alternatives><graphic xlink:href="pone.0244474.e103.jpg" id="pone.0244474.e103g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M103"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> and mobility does not necessarily constitute evidence against the effectiveness of lockdowns. On the contrary, it is possible that lockdowns reinforce attitudes towards disease-awareness and self-isolation, helping to ensure lower values of <inline-formula id="pone.0244474.e104"><alternatives><graphic xlink:href="pone.0244474.e104.jpg" id="pone.0244474.e104g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M104"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> in the long run.</p>
                <fig id="pone.0244474.g004" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0244474.g004</object-id>
                  <label>Fig 4</label>
                  <caption>
                    <title>Mobility around introduction of lockdowns.</title>
                    <p>Mobility index (constructed from Google’s “COVID-19 Community Mobility Reports” [<xref rid="pone.0244474.ref024" ref-type="bibr">24</xref>]) one week before and three weeks after a lockdown is introduced in a country. See <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref> (Section A.8) for details on the construction of the mobility index. The original sample consists of 14 European countries studied by Flaxman et al [<xref rid="pone.0244474.ref025" ref-type="bibr">25</xref>]. Heteroskedasticity-robust confidence bounds are shown by the shaded areas.</p>
                  </caption>
                  <graphic xlink:href="pone.0244474.g004"/>
                </fig>
                <p>A potential concern with the evidence in <xref ref-type="fig" rid="pone.0244474.g003">Fig 3</xref> is that our estimates of <inline-formula id="pone.0244474.e105"><alternatives><graphic xlink:href="pone.0244474.e105.jpg" id="pone.0244474.e105g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M105"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> use information from the full sample. Hence, estimates of <inline-formula id="pone.0244474.e106"><alternatives><graphic xlink:href="pone.0244474.e106.jpg" id="pone.0244474.e106g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M106"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula>
<italic>before</italic> the lockdown implicitly depend on the estimates of <inline-formula id="pone.0244474.e107"><alternatives><graphic xlink:href="pone.0244474.e107.jpg" id="pone.0244474.e107g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M107"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula>
<italic>after</italic> the lockdown. This feature of the estimation procedure may result in low statistical power to detect any effects of NPIs. To investigate this possibility, we conduct a power analysis (see Section A.11 in <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref>). Given our empirical estimates of signal-to-noise ratios, we find that the statistical procedure appears sufficiently powerful to detect moderate changes in <inline-formula id="pone.0244474.e108"><alternatives><graphic xlink:href="pone.0244474.e108.jpg" id="pone.0244474.e108g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M108"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula>.</p>
                <p>To assess the effects of NPIs more formally, we employ the following fixed-effect regressions (<xref rid="pone.0244474.t002" ref-type="table">Table 2</xref>). Specifically, we regress <inline-formula id="pone.0244474.e109"><alternatives><graphic xlink:href="pone.0244474.e109.jpg" id="pone.0244474.e109g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M109"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> on a set of indicator variables capturing interventions and different types of fixed effects:
<disp-formula id="pone.0244474.e110"><alternatives><graphic xlink:href="pone.0244474.e110.jpg" id="pone.0244474.e110g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M110"><mml:mrow><mml:mo form="prefix">log</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mtext>fixed</mml:mtext><mml:mspace width="4pt"/><mml:mtext>effects</mml:mtext><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mn>5</mml:mn></mml:munderover><mml:msub><mml:mi>β</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msubsup><mml:mtext>NPI</mml:mtext><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>j</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>u</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>
where <italic>u</italic><sub><italic>i</italic>,<italic>t</italic></sub> denotes the stochastic error term of the regression. The <inline-formula id="pone.0244474.e111"><alternatives><graphic xlink:href="pone.0244474.e111.jpg" id="pone.0244474.e111g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M111"><mml:msubsup><mml:mtext>NPI</mml:mtext><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>j</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> is an indicator variable that equals 1 after the <italic>j</italic>-th NPI is introduced, and zero before its introduction. The index <italic>i</italic> denotes countries, and <italic>t</italic> stands for the number of days since the outbreak of the epidemic.</p>
                <table-wrap id="pone.0244474.t002" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0244474.t002</object-id>
                  <label>Table 2</label>
                  <caption>
                    <title>Effective reproduction number after introduction of NPIs.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0244474.t002g" xlink:href="pone.0244474.t002"/>
                    <table frame="box" rules="all" border="0">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="2" colspan="1"/>
                          <th align="center" colspan="4" rowspan="1"><italic>Dependent Variable: log</italic>(<italic>R</italic><sub><italic>t</italic></sub>)</th>
                        </tr>
                        <tr>
                          <th align="center" rowspan="1" colspan="1">(1)</th>
                          <th align="center" rowspan="1" colspan="1">(2)</th>
                          <th align="center" rowspan="1" colspan="1">(3)</th>
                          <th align="center" rowspan="1" colspan="1">(4)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="2" colspan="1">Lockdown</td>
                          <td align="center" rowspan="1" colspan="1">-0.65<xref ref-type="table-fn" rid="t002fn003">***</xref></td>
                          <td align="center" rowspan="1" colspan="1">-0.13<xref ref-type="table-fn" rid="t002fn002">**</xref></td>
                          <td align="center" rowspan="1" colspan="1">-0.1<xref ref-type="table-fn" rid="t002fn002">**</xref></td>
                          <td align="center" rowspan="1" colspan="1">-0.04</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">(0.04)</td>
                          <td align="center" rowspan="1" colspan="1">(0.05)</td>
                          <td align="center" rowspan="1" colspan="1">(0.05)</td>
                          <td align="center" rowspan="1" colspan="1">(0.06)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" colspan="1">Public Events</td>
                          <td align="center" rowspan="1" colspan="1">-0.09<xref ref-type="table-fn" rid="t002fn001">*</xref></td>
                          <td align="center" rowspan="1" colspan="1">0.22<xref ref-type="table-fn" rid="t002fn003">***</xref></td>
                          <td align="center" rowspan="1" colspan="1">0.21<xref ref-type="table-fn" rid="t002fn003">***</xref></td>
                          <td align="center" rowspan="1" colspan="1">0.36<xref ref-type="table-fn" rid="t002fn003">***</xref></td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">(0.04)</td>
                          <td align="center" rowspan="1" colspan="1">(0.04)</td>
                          <td align="center" rowspan="1" colspan="1">(0.04)</td>
                          <td align="center" rowspan="1" colspan="1">(0.08)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" colspan="1">School Closure</td>
                          <td align="center" rowspan="1" colspan="1">-0.02</td>
                          <td align="center" rowspan="1" colspan="1">-0.19<xref ref-type="table-fn" rid="t002fn003">***</xref></td>
                          <td align="center" rowspan="1" colspan="1">-0.18<xref ref-type="table-fn" rid="t002fn003">***</xref></td>
                          <td align="center" rowspan="1" colspan="1">-0.1</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">(0.06)</td>
                          <td align="center" rowspan="1" colspan="1">(0.05)</td>
                          <td align="center" rowspan="1" colspan="1">(0.06)</td>
                          <td align="center" rowspan="1" colspan="1">(0.08)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" colspan="1">Self Isolation</td>
                          <td align="center" rowspan="1" colspan="1">-0.13<xref ref-type="table-fn" rid="t002fn002">**</xref></td>
                          <td align="center" rowspan="1" colspan="1">-0.09<xref ref-type="table-fn" rid="t002fn002">**</xref></td>
                          <td align="center" rowspan="1" colspan="1">-0.04</td>
                          <td align="center" rowspan="1" colspan="1">0.01</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">(0.06)</td>
                          <td align="center" rowspan="1" colspan="1">(0.05)</td>
                          <td align="center" rowspan="1" colspan="1">(0.05)</td>
                          <td align="center" rowspan="1" colspan="1">(0.08)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" colspan="1">Social Distancing</td>
                          <td align="center" rowspan="1" colspan="1">-0.15<xref ref-type="table-fn" rid="t002fn002">**</xref></td>
                          <td align="center" rowspan="1" colspan="1">-0.08</td>
                          <td align="center" rowspan="1" colspan="1">-0.11<xref ref-type="table-fn" rid="t002fn001">*</xref></td>
                          <td align="center" rowspan="1" colspan="1">-0.14<xref ref-type="table-fn" rid="t002fn001">*</xref></td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">(0.06)</td>
                          <td align="center" rowspan="1" colspan="1">(0.06)</td>
                          <td align="center" rowspan="1" colspan="1">(0.06)</td>
                          <td align="center" rowspan="1" colspan="1">(0.08)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>N</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">855</td>
                          <td align="center" rowspan="1" colspan="1">855</td>
                          <td align="center" rowspan="1" colspan="1">848</td>
                          <td align="center" rowspan="1" colspan="1">488</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>R</italic>
                            <sup>2</sup>
                          </td>
                          <td align="center" rowspan="1" colspan="1">0.53</td>
                          <td align="center" rowspan="1" colspan="1">0.87</td>
                          <td align="center" rowspan="1" colspan="1">0.88</td>
                          <td align="center" rowspan="1" colspan="1">0.91</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Country FE</td>
                          <td align="center" rowspan="1" colspan="1">✔</td>
                          <td align="center" rowspan="1" colspan="1">✔</td>
                          <td align="center" rowspan="1" colspan="1">✔</td>
                          <td align="center" rowspan="1" colspan="1">✔</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Days-Since-Outbreak FE</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">✔</td>
                          <td align="center" rowspan="1" colspan="1">✔</td>
                          <td align="center" rowspan="1" colspan="1">✔</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Mobility Controls</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">✔</td>
                          <td align="center" rowspan="1" colspan="1">✔</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Testing Controls</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">✔</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t002fn001">
                      <p>* <italic>p</italic> &lt;0.1;</p>
                    </fn>
                    <fn id="t002fn002">
                      <p>** <italic>p</italic> &lt;0.05;</p>
                    </fn>
                    <fn id="t002fn003">
                      <p>*** <italic>p</italic> &lt;0.01</p>
                    </fn>
                    <fn id="t002fn004">
                      <p>Results of panel-data regressions of the (log of) effective reproduction number (<inline-formula id="pone.0244474.e112"><alternatives><graphic id="pone.0244474.e112g" xlink:href="pone.0244474.e112"/><mml:math id="M112"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula>) on indicator variables that are equal to 1 after the introduction of a non-pharmaceutical intervention (NPI) and 0 before the introduction. The sample consists of 14 European countries studied by Flaxman et al [<xref rid="pone.0244474.ref025" ref-type="bibr">25</xref>]. Regressions always include country fixed effects; regressions in columns (2)–(4) also include days-since-outbreak fixed effects. Outbreak is defined as the date on which 100 cases of COVID-19 are reached. The regression with mobility controls in (3) includes the one- and two-week lags of the mobility index; see <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref> (Section A.8) for details. The regression with testing controls in (4) controls for the change in the number of daily tests per capita conducted in the country. To allow for reasonably precise estimation of days-since-outbreak fixed effects, we only consider days after the outbreak for which we have data for at least 5 countries. Heteroskedasticity-robust standard errors in parentheses.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Column (1) of <xref rid="pone.0244474.t002" ref-type="table">Table 2</xref> provides estimated effects of NPIs when only country fixed effects are included. We observe a strong negative effect of lockdowns, social distancing, and measures of self isolation. Taken at face value, the estimates suggest that lockdowns reduce <inline-formula id="pone.0244474.e113"><alternatives><graphic xlink:href="pone.0244474.e113.jpg" id="pone.0244474.e113g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M113"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> by 65%. School closures are not statistically significant in this specification. These regressions as well the point estimates are similar to the statistical analysis performed by Flaxman et al [<xref rid="pone.0244474.ref025" ref-type="bibr">25</xref>].</p>
                <p>The regression with country fixed effects only, however, is likely misspecified. Implicitly, such a specification assumes that the only reason <inline-formula id="pone.0244474.e114"><alternatives><graphic xlink:href="pone.0244474.e114.jpg" id="pone.0244474.e114g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M114"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> can fall is because of introduction of NPIs. However, <inline-formula id="pone.0244474.e115"><alternatives><graphic xlink:href="pone.0244474.e115.jpg" id="pone.0244474.e115g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M115"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> would likely trend downwards even in the absence of any public policy interventions. First, <inline-formula id="pone.0244474.e116"><alternatives><graphic xlink:href="pone.0244474.e116.jpg" id="pone.0244474.e116g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M116"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> tends to fall during an epidemic as the number of susceptibles is depleted. Second, people may adjust their behavior even in the absence of any policy measures. Failing to control for the dynamics of <inline-formula id="pone.0244474.e117"><alternatives><graphic xlink:href="pone.0244474.e117.jpg" id="pone.0244474.e117g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M117"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> in the absence of NPIs therefore likely leads to an over-estimation of the effects of NPIs.</p>
                <p>We acknowledge that obtaining credible counterfactuals in the present empirical context is extremely challenging. However, we can exploit the panel structure of the dataset to reduce the potential issues in the previous specification. We do so by including days-since-outbreak fixed effects. Intuitively, with such fixed effects we are comparing <inline-formula id="pone.0244474.e118"><alternatives><graphic xlink:href="pone.0244474.e118.jpg" id="pone.0244474.e118g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M118"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula>’s in two countries (e.g., country A and country B) that are both five days from the outbreak (say), with a school closure in country A but not in country B.</p>
                <p>The results from the regression with days-since-outbreak fixed effects are shown in column (2). The coefficient for lockdowns becomes substantially smaller in absolute value and less statistically significant. The coefficients for self-isolation and social-distancing measures are also reduced and lose some of their statistical significance. The coefficient for public events is highly statistically significant but positive rather than negative. A naïve interpretation would suggest that banning public events has a positive effect on <inline-formula id="pone.0244474.e119"><alternatives><graphic xlink:href="pone.0244474.e119.jpg" id="pone.0244474.e119g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M119"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula>. More likely, however, is that the positive coefficient is due to countries where <inline-formula id="pone.0244474.e120"><alternatives><graphic xlink:href="pone.0244474.e120.jpg" id="pone.0244474.e120g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M120"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> is declining more slowly being faster to ban public events. In <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref> (Section A.14), we show that the results remain similar when the NPIs are included separately, reducing concerns about potential multicollinearity problems between the different NPI variables.</p>
                <p>In column (3), we also include lagged mobility variables as additional controls. With mobility controls, the coefficient on lockdowns is further reduced. School closures and social-distancing measures are estimated to have a statistically-significant negative effect on <inline-formula id="pone.0244474.e121"><alternatives><graphic xlink:href="pone.0244474.e121.jpg" id="pone.0244474.e121g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M121"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula>, with reducing <inline-formula id="pone.0244474.e122"><alternatives><graphic xlink:href="pone.0244474.e122.jpg" id="pone.0244474.e122g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M122"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula> by 18% and 11%, respectively.</p>
                <p>A potential concern is that countries may introduce NPIs and simultaneously increase the number of tests for COVID-19 that they perform. To help alleviate this concern, in column (4) we add the change in the daily number of tests per capita as an additional explanatory variable. The data on daily tests per capita comes from <italic>Our World in Data</italic> [<xref rid="pone.0244474.ref023" ref-type="bibr">23</xref>]. With testing controls, most coefficients are no longer statistically significant. Note, however, that the sample size is reduced significantly as we do not have testing data for all countries in the sample.</p>
                <p>We caution readers against over-interpreting the results of this section. Obtaining unbiased estimates of the true causal impact of NPIs is exceptionally challenging. As a result, even our best estimates might still suffer from statistical issues such as unobservable confounding variables or simultaneity bias. In particular, the timing of NPIs is not random. Countries that introduced NPIs earlier likely did so because they had previously observed a stubbornly high <inline-formula id="pone.0244474.e123"><alternatives><graphic xlink:href="pone.0244474.e123.jpg" id="pone.0244474.e123g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M123"><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula>. In that case, the dependent and independent variables would be simultaneously determined, yielding biased estimates. Moreover, since we cannot directly observe peoples’ attitudes towards COVID-19 or government policies, we cannot control for other variables affecting human behavior. These potential issues notwithstanding, we find that people adjusted their mobility patterns <italic>before</italic> the introduction of lockdowns. We believe that these findings bolster the importance of accounting for changes in human behavior when evaluating the effects of NPIs.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec011">
              <title>Conclusion</title>
              <p>In this paper we develop a new way to estimate the effective reproduction number of an infectious disease (<inline-formula id="pone.0244474.e124"><alternatives><graphic xlink:href="pone.0244474.e124.jpg" id="pone.0244474.e124g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M124"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula>). Our estimation method exploits a structural mapping between <inline-formula id="pone.0244474.e125"><alternatives><graphic xlink:href="pone.0244474.e125.jpg" id="pone.0244474.e125g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M125"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> and the growth rate of the number of infected individuals derived from the basic SIR model. The new methodology is straightforward to apply in practice, and according to our simulation checks, it yields accurate estimates. We use the new method to track <inline-formula id="pone.0244474.e126"><alternatives><graphic xlink:href="pone.0244474.e126.jpg" id="pone.0244474.e126g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M126"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> of COVID-19 around the world, and assess the effectiveness of public policy interventions in a sample of European countries.</p>
              <p>The current paper faces several limitations. First, a local-level specification for the growth rate implicitly assumes that the growth rate of the number of infected individuals remains forever in flux. However, in the long-run, this growth rate must converge to zero. Since our model does not capture this feature, it seems likely that our estimated confidence bounds are overly conservative in the late stages of an epidemic. Second, when applying the model to cross-country data, one may achieve important gains in statistical efficiency if the model is estimated jointly for all countries (for example, by estimating a multivariate local-level model). Finally, for assessing the effects of NPIs more accurately, it would be desirable to collect data for a larger sample of countries.</p>
              <p>Our estimates of <inline-formula id="pone.0244474.e127"><alternatives><graphic xlink:href="pone.0244474.e127.jpg" id="pone.0244474.e127g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M127"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> for COVID-19 are based on a structural relationship derived from the SIR model. By using the SIR model, we omit some features of the disease that are likely important when modeling its spread. In particular, the SIR model abstracts away from incubation periods as well as transmission during the incubation period. Nevertheless, we prefer the SIR specification, for two reasons. First, in simulations, we find that our estimator produces accurate estimates even when the true model is SEIR rather than SIR, as we show in <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref> (Section A.5). Second, we believe that the SIR model is likely to produce more reliable estimates in practice. To use the SEIR model, we would have to estimate the number of currently exposed individuals. Doing so would triple the number of model parameters. In particular, we would have to calibrate the (i) average duration of the incubation period (<italic>κ</italic><sup>−1</sup>); and (ii) relative infectiousness of exposed and infectious individuals (<italic>ϵ</italic>); see <xref ref-type="supplementary-material" rid="pone.0244474.s001">S1 Appendix</xref> (Section A.5) for details. While <italic>κ</italic> is arguably constant across countries, <italic>ϵ</italic> is unlikely to be fixed over countries and over time. For example, greater mask usage is likely to reduce <italic>ϵ</italic> by differentially affecting transmission by symptomatic and pre- or asymptomatic individuals. Allowing for such time variation in <italic>ϵ</italic>, in addition to time-varying transmission rates (<italic>β</italic><sub><italic>t</italic></sub>), is challenging. That said, it is possible to extend this paper’s ideas to models that are richer than the SIR model. Doing so may be an exciting avenue for future research.</p>
              <p>Relative to existing methods for estimating <inline-formula id="pone.0244474.e128"><alternatives><graphic xlink:href="pone.0244474.e128.jpg" id="pone.0244474.e128g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M128"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula>, we combine basic epidemiological theory with standard time-series filtering techniques, particularly Kalman filtering. This approach leads to a transparent closed-form estimator. The simplicity of the estimator allows us to study some of its properties analytically (e.g., the effects of potential data problems). Differently from most existing approaches, our method can be applied using both Bayesian and frequentist techniques, and it does not require any tuning parameters beyond specifying the average serial interval. On the other hand, relative to less structural approaches such as that of Cori et al [<xref rid="pone.0244474.ref003" ref-type="bibr">3</xref>], our estimator may be more sensitive to potential model misspecification. Empirically, we find that our estimates and estimates obtained by the Cori et al method are highly positively correlated (average correlation: 0.80). However, the correlations are not perfect, suggesting that there is value in combining both estimators when tracking infectious diseases. Hence, our methodology brings an additional instrument to the researcher’s toolbox.</p>
              <p>In our empirical application, we find that lockdowns, measures of self-isolation, and social distancing all have statistically significant effects on reducing <inline-formula id="pone.0244474.e129"><alternatives><graphic xlink:href="pone.0244474.e129.jpg" id="pone.0244474.e129g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M129"><mml:mi mathvariant="script">R</mml:mi></mml:math></alternatives></inline-formula> of COVID-19. However, we also demonstrate the importance of accounting for voluntary changes in behavior. In particular, most of the decline in mobility in our sample took place before lockdowns were introduced. This finding suggests that people respond to the risk of contracting the virus by changing their mobility patterns and reducing social interactions. Failing to account for such voluntary changes in behavior yields estimated effects of NPIs that are arguably too large.</p>
              <p>Given that even our best estimates may still be biased, it is important to interpret these results cautiously. However, from an economic perspective, these findings point to large private incentives to avoid infection. These incentives can induce a contraction in economic activity as people voluntarily choose to self-isolate [<xref rid="pone.0244474.ref048" ref-type="bibr">48</xref>–<xref rid="pone.0244474.ref050" ref-type="bibr">50</xref>]. As a result, even if countries lift the NPIs that are currently in place, it is not clear whether people would voluntarily return to their pre-pandemic mobility and consumption patterns. Our real-time estimator may be used to track the dynamics of COVID-19 as the current restrictions are relaxed.</p>
            </sec>
            <sec sec-type="supplementary-material" id="sec012">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data" id="pone.0244474.s001">
                <label>S1 Appendix</label>
                <caption>
                  <title>Supplementary appendix.</title>
                  <p>Supplementary appendix containing additional theoretical and simulation results, data descriptions, and further empirical analysis.</p>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0244474.s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0244474.s002">
                <label>S1 File</label>
                <caption>
                  <title>Replication files.</title>
                  <p>Replication package for replicating all of the statistical analysis and simulation results provided in the paper.</p>
                  <p>(ZIP)</p>
                </caption>
                <media xlink:href="pone.0244474.s002.zip">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>We would like to thank Christiane Baumeister, Ralph Brinks, Eric Budish, Ricardo Hausmann, Artūras Juodis, Jan Keil, Siem Jan Koopman, Andrés Neumeyer, Mathieu Pedemonte, Sergio Ocampo-Díaz, Sándor Sóvágó, Eduardo Undurraga, Iván Werning, as well as seminar participants at the Central Bank of Chile and Harvard Growth Lab for their comments and suggestions. We also thank Chen Lin for excellent research assistance. The views and conclusions presented in this paper are exclusively those of the authors and do not necessarily reflect the position of the Central Bank of Chile or of the Board members.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="pone.0244474.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Wallinga</surname><given-names>J</given-names></name>, <name><surname>Teunis</surname><given-names>P</given-names></name>. <article-title>Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures</article-title>. <source>American Journal of Epidemiology</source>. <year>2004</year>;<volume>160</volume>(<issue>6</issue>):<fpage>509</fpage>–<lpage>516</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwh255</pub-id><pub-id pub-id-type="pmid">15353409</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref002">
                <label>2</label>
                <mixed-citation publication-type="book"><name><surname>Nishiura</surname><given-names>H</given-names></name>, <name><surname>Chowell</surname><given-names>G</given-names></name>. <chapter-title>The Effective Reproduction Number as a Prelude to Statistical Estimation of Time-Dependent Epidemic Trends</chapter-title> In: <name><surname>Chowell</surname><given-names>G</given-names></name>, <name><surname>Hyman</surname><given-names>JM</given-names></name>, <name><surname>Bettencourt</surname><given-names>LMA</given-names></name>, <name><surname>Castillo-Chavez</surname><given-names>C</given-names></name>, editors. <source>Mathematical and Statistical Estimation Approaches in Epidemiology</source>. <publisher-name>Springer</publisher-name>; <year>2009</year> p. <fpage>103</fpage>–<lpage>122</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Cori</surname><given-names>A</given-names></name>, <name><surname>Ferguson</surname><given-names>NM</given-names></name>, <name><surname>Fraser</surname><given-names>C</given-names></name>, <name><surname>Cauchemez</surname><given-names>S</given-names></name>. <article-title>A new framework and software to estimate time-varying reproduction numbers during epidemics</article-title>. <source>American Journal of Epidemiology</source>. <year>2013</year>;<volume>178</volume>(<issue>9</issue>):<fpage>1505</fpage>–<lpage>1512</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwt133</pub-id><pub-id pub-id-type="pmid">24043437</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Dietz</surname><given-names>K</given-names></name>. <article-title>The estimation of the basic reproduction number for infectious diseases</article-title>. <source>Statistical Methods in Medical Research</source>. <year>1993</year>;<volume>2</volume>(<issue>1</issue>):<fpage>23</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">8261248</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref005">
                <label>5</label>
                <mixed-citation publication-type="book"><name><surname>Chowell</surname><given-names>G</given-names></name>, <name><surname>Brauer</surname><given-names>F</given-names></name>. <chapter-title>The Basic Reproduction Number of Infectious Diseases: Computation and Estimation Using Compartmental Epidemic Models</chapter-title> In: <name><surname>Chowell</surname><given-names>G</given-names></name>, <name><surname>Hyman</surname><given-names>JM</given-names></name>, <name><surname>Bettencourt</surname><given-names>LMA</given-names></name>, <name><surname>Castillo-Chavez</surname><given-names>C</given-names></name>, editors. <source>Mathematical and Statistical Estimation Approaches in Epidemiology</source>. <publisher-name>Springer</publisher-name>; <year>2009</year> p. <fpage>1</fpage>–<lpage>30</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Delamater</surname><given-names>PL</given-names></name>, <name><surname>Street</surname><given-names>EJ</given-names></name>, <name><surname>Leslie</surname><given-names>TF</given-names></name>, <name><surname>Yang</surname><given-names>YT</given-names></name>, <name><surname>Jacobsen</surname><given-names>KH</given-names></name>. <article-title>Complexity of the basic reproduction number (R0)</article-title>. <source>Emerging Infectious Diseases</source>. <year>2019</year>;<volume>25</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>4</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Atkeson</surname><given-names>A</given-names></name>. <article-title>What Will Be the Economic Impact of COVID-19 in the US? Rough Estimates of Disease Scenarios</article-title>. <source>NBER Working Paper</source>. <year>2020</year>;<volume>26867</volume>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref008">
                <label>8</label>
                <mixed-citation publication-type="other">Leung G. Lockdown Can’t Last Forever. Here’s How to Lift It; 2020. The New York Times (<ext-link ext-link-type="uri" xlink:href="https://nyti.ms/3dWXHZR">https://nyti.ms/3dWXHZR</ext-link>).</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Chinazzi</surname><given-names>M</given-names></name>, <name><surname>Davis</surname><given-names>JT</given-names></name>, <name><surname>Ajelli</surname><given-names>M</given-names></name>, <name><surname>Gioannini</surname><given-names>C</given-names></name>, <name><surname>Litvinova</surname><given-names>M</given-names></name>, <name><surname>Merler</surname><given-names>S</given-names></name>, <etal>et al</etal><article-title>The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak</article-title>. <source>Science</source>. <year>2020</year>;<volume>9757</volume>(<issue>March</issue>):<fpage>1</fpage>–<lpage>12</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Kucharski</surname><given-names>AJ</given-names></name>, <name><surname>Russell</surname><given-names>TW</given-names></name>, <name><surname>Diamond</surname><given-names>C</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Edmunds</surname><given-names>J</given-names></name>, <name><surname>Funk</surname><given-names>S</given-names></name>, <etal>et al</etal><article-title>Early dynamics of transmission and control of COVID-19: a mathematical modelling study</article-title>. <source>The Lancet Infectious Diseases</source>. <year>2020</year>;<volume>3099</volume>(<issue>20</issue>):<fpage>1</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(20)30144-4</pub-id>
<?supplied-pmid 32171059?><pub-id pub-id-type="pmid">32171059</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>H</given-names></name>, <name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Dong</surname><given-names>Y</given-names></name>, <name><surname>Chang</surname><given-names>R</given-names></name>, <name><surname>Xu</surname><given-names>C</given-names></name>, <name><surname>Yu</surname><given-names>X</given-names></name>, <etal>et al</etal><article-title>Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China</article-title>. <source>Cell Discovery</source>. <year>2020</year>;<volume>6</volume>(<issue>1</issue>):<fpage>4</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1038/s41421-019-0138-2</pub-id>
<?supplied-pmid 32025334?><pub-id pub-id-type="pmid">32025334</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref012">
                <label>12</label>
                <mixed-citation publication-type="other">Budish E. R &lt; 1 as an Economic Constraint: Can We “Expand the Frontier” in the Fight Against Covid-19?; 2020. <pub-id pub-id-type="doi">10.2139/ssrn.3567068</pub-id>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Kermack</surname><given-names>WO</given-names></name>, <name><surname>McKendrick</surname><given-names>AG</given-names></name>. <article-title>A contribution to the mathematical theory of epidemics</article-title>. <source>Proceedings of the Royal Society A</source>. <year>1927</year>;<volume>115</volume>(<issue>772</issue>):<fpage>700</fpage>–<lpage>721</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref014">
                <label>14</label>
                <mixed-citation publication-type="other">Arroyo-Marioli F, Bullano F, Kučinskas S, Rondón-Moreno C. Tracking R of COVID-19: Online Dashboard; 2020. <ext-link ext-link-type="uri" xlink:href="https://bit.ly/Rtlive">https://bit.ly/Rtlive</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref015">
                <label>15</label>
                <mixed-citation publication-type="other">Gostic K, McGough L, Baskerville E, Abbott S, Joshi K, Tedijanto C, et al. Practical considerations for measuring the effective reproductive number, Rt; 2020. <pub-id pub-id-type="doi">10.1101/2020.06.18.20134858</pub-id>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Chowell</surname><given-names>G</given-names></name>, <name><surname>Nishiura</surname><given-names>H</given-names></name>, <name><surname>Bettencourt</surname><given-names>LMA</given-names></name>. <article-title>Comparative estimation of the reproduction number for pandemic influenza from daily case notification data</article-title>. <source>Journal of the Royal Society Interface</source>. <year>2007</year>;<volume>4</volume>(<issue>12</issue>):<fpage>154</fpage>–<lpage>166</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Cazelles</surname><given-names>B</given-names></name>, <name><surname>Champagne</surname><given-names>C</given-names></name>, <name><surname>Dureau</surname><given-names>J</given-names></name>. <article-title>Accounting for non-stationarity in epidemiology by embedding time-varying parameters in stochastic models</article-title>. <source>PLoS Computational Biology</source>. <year>2018</year>;<volume>14</volume>(<issue>8</issue>):<fpage>1</fpage>–<lpage>26</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Dehning</surname><given-names>J</given-names></name>, <name><surname>Zierenberg</surname><given-names>J</given-names></name>, <name><surname>Spitzner</surname><given-names>FP</given-names></name>, <name><surname>Wibral</surname><given-names>M</given-names></name>, <name><surname>Neto</surname><given-names>JP</given-names></name>, <name><surname>Wilczek</surname><given-names>M</given-names></name>, <etal>et al</etal><article-title>Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions</article-title>. <source>Science</source>. <year>2020</year>;<volume>369</volume>(<issue>6500</issue>):<fpage>0</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1126/science.abb9789</pub-id>
<?supplied-pmid 32414780?><pub-id pub-id-type="pmid">32414780</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Wallinga</surname><given-names>J</given-names></name>, <name><surname>Lipsitch</surname><given-names>M</given-names></name>. <article-title>How generation intervals shape the relationship between growth rates and reproductive numbers</article-title>. <source>Proceedings of the Royal Society B: Biological Sciences</source>. <year>2007</year>;<volume>274</volume>(<issue>1609</issue>):<fpage>599</fpage>–<lpage>604</lpage>. <pub-id pub-id-type="doi">10.1098/rspb.2006.3754</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Thompson</surname><given-names>RN</given-names></name>, <name><surname>Stockwin</surname><given-names>JE</given-names></name>, <name><surname>van Gaalen</surname><given-names>RD</given-names></name>, <name><surname>Polonsky</surname><given-names>JA</given-names></name>, <name><surname>Kamvar</surname><given-names>ZN</given-names></name>, <name><surname>Demarsh</surname><given-names>PA</given-names></name>, <etal>et al</etal><article-title>Improved inference of time-varying reproduction numbers during infectious disease outbreaks</article-title>. <source>Epidemics</source>. <year>2019</year>;<volume>29</volume>(<issue>March</issue>). <pub-id pub-id-type="doi">10.1016/j.epidem.2019.100356</pub-id><?supplied-pmid 31624039?><pub-id pub-id-type="pmid">31624039</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Bettencourt</surname><given-names>LMA</given-names></name>, <name><surname>Ribeiro</surname><given-names>RM</given-names></name>. <article-title>Real time Bayesian estimation of the epidemic potential of emerging infectious diseases</article-title>. <source>PLoS ONE</source>. <year>2008</year>;<volume>3</volume>(<issue>5</issue>):<fpage>1</fpage>–<lpage>9</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Dong</surname><given-names>E</given-names></name>, <name><surname>Du</surname><given-names>H</given-names></name>, <name><surname>Gardner</surname><given-names>L</given-names></name>. <article-title>An interactive web-based dashboard to track COVID-19 in real time</article-title>. <source>The Lancet</source>. <year>2020</year>;<volume>3099</volume>(<issue>20</issue>):<fpage>19</fpage>–<lpage>20</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref023">
                <label>23</label>
                <mixed-citation publication-type="other">Our World in Data. Coronavirus Disease (COVID-19)—Statistics and Research; 2020. <ext-link ext-link-type="uri" xlink:href="https://ourworldindata.org/coronavirus">https://ourworldindata.org/coronavirus</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref024">
                <label>24</label>
                <mixed-citation publication-type="other">Google. Google COVID-19 Community Mobility Reports; 2020. <ext-link ext-link-type="uri" xlink:href="https://www.google.com/covid19/mobility/">https://www.google.com/covid19/mobility/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref025">
                <label>25</label>
                <mixed-citation publication-type="other">Flaxman S, Mishra S, Gandy A, Unwin JT, Coupland H, Mellan TA, et al. Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries; 2020. <pub-id pub-id-type="doi">10.25561/77731</pub-id>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref026">
                <label>26</label>
                <mixed-citation publication-type="other">Flaxman S, Mishra S, Gandy A, Unwin JT, Coupland H, Mellan TA, et al. Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 14 European countries: Technical description update; 2020. <ext-link ext-link-type="uri" xlink:href="https://arxiv.org/abs/2004.11342">https://arxiv.org/abs/2004.11342</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Allen</surname><given-names>LJS</given-names></name>, <name><surname>Van Den Driessche</surname><given-names>P</given-names></name>. <article-title>The basic reproduction number in some discrete-time epidemic models</article-title>. <source>Journal of Difference Equations and Applications</source>. <year>2008</year>;<volume>14</volume>(<issue>10-11</issue>):<fpage>1127</fpage>–<lpage>1147</lpage>. <pub-id pub-id-type="doi">10.1080/10236190802332308</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Stock</surname><given-names>JH</given-names></name>. <article-title>Data Gaps and the Policy Response to the Novel Coronavirus</article-title>. <source>NBER Working Paper</source>. <year>2020</year>;<volume>26902</volume>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Ma</surname><given-names>J</given-names></name>. <article-title>Estimating epidemic exponential growth rate and basic reproduction number</article-title>. <source>Infectious Disease Modelling</source>. <year>2020</year>;<volume>5</volume>:<fpage>129</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1016/j.idm.2019.12.009</pub-id><pub-id pub-id-type="pmid">31956741</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref030">
                <label>30</label>
                <mixed-citation publication-type="book"><name><surname>Durbin</surname><given-names>J</given-names></name>, <name><surname>Koopman</surname><given-names>SJ</given-names></name>. <source>Time Series Analysis by State Space Methods</source>. <publisher-loc>Oxford</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>2012</year>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Muth</surname><given-names>JF</given-names></name>. <article-title>Optimal Properties of Exponentially Weighted Forecasts</article-title>. <source>Journal of the American Statistical Association</source>. <year>1960</year>;<volume>55</volume>(<issue>290</issue>):<fpage>299</fpage>–<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1080/01621459.1960.10482064</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref032">
                <label>32</label>
                <mixed-citation publication-type="book"><name><surname>Commandeur</surname><given-names>JJF</given-names></name>, <name><surname>Koopman</surname><given-names>SJ</given-names></name>. <source>Introduction to State Space Time Series Analysis</source>. <publisher-loc>Oxford</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>2007</year>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Carter</surname><given-names>CK</given-names></name>, <name><surname>Kohn</surname><given-names>R</given-names></name>. <article-title>On Gibbs sampling for state space models</article-title>. <source>Biometrika</source>. <year>1994</year>;<volume>81</volume>(<issue>3</issue>):<fpage>541</fpage>–<lpage>553</lpage>. <pub-id pub-id-type="doi">10.1093/biomet/81.3.541</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Creal</surname><given-names>D</given-names></name>. <article-title>A Survey of Sequential Monte Carlo Methods for Economics and Finance</article-title>. <source>Econometric Reviews</source>. <year>2012</year>;<volume>31</volume>(<issue>3</issue>):<fpage>245</fpage>–<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1080/07474938.2011.607333</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Arons</surname><given-names>MM</given-names></name>, <name><surname>Hatfield</surname><given-names>KM</given-names></name>, <name><surname>Reddy</surname><given-names>SC</given-names></name>, <name><surname>Kimball</surname><given-names>A</given-names></name>, <name><surname>James</surname><given-names>A</given-names></name>, <name><surname>Jacobs</surname><given-names>JR</given-names></name>, <etal>et al</etal><article-title>Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility</article-title>. <source>New England Journal of Medicine</source>. <year>2020</year>; p. <fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa2008457</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Nishiura</surname><given-names>H</given-names></name>, <name><surname>Kobayashi</surname><given-names>T</given-names></name>, <name><surname>Miyama</surname><given-names>T</given-names></name>, <name><surname>Suzuki</surname><given-names>A</given-names></name>, <name><surname>mok Jung</surname><given-names>S</given-names></name>, <name><surname>Hayashi</surname><given-names>K</given-names></name>, <etal>et al</etal><article-title>Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)</article-title>. <source>International Journal of Infectious Diseases</source>. <year>2020</year>;<volume>94</volume>:<fpage>154</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2020.03.020</pub-id>
<?supplied-pmid 32179137?><pub-id pub-id-type="pmid">32179137</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref037">
                <label>37</label>
                <mixed-citation publication-type="other">Streeck H, Schulte B, Kümmerer BM, Richter E, Höller T, Fuhrmann C, et al. Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event; 2020. <pub-id pub-id-type="doi">10.1101/2020.05.04.20090076</pub-id>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Maier</surname><given-names>BF</given-names></name>, <name><surname>Brockmann</surname><given-names>D</given-names></name>. <article-title>Effective containment explains sub-exponential growth in confirmed cases of recent COVID-19 cases in China</article-title>. <source>Science</source>. <year>2020</year>;<volume>4557</volume>(<issue>April</issue>):<fpage>1</fpage>–<lpage>8</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Prem</surname><given-names>K</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Russell</surname><given-names>TW</given-names></name>, <name><surname>Kucharski</surname><given-names>AJ</given-names></name>, <name><surname>Eggo</surname><given-names>RM</given-names></name>, <name><surname>Davies</surname><given-names>N</given-names></name>, <etal>et al</etal><article-title>The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study</article-title>. <source>The Lancet Public Health</source>. <year>2020</year>;<volume>2667</volume>(<issue>20</issue>):<fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/S2468-2667(20)30073-6</pub-id>
<?supplied-pmid 32220655?><pub-id pub-id-type="pmid">32220655</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Nishiura</surname><given-names>H</given-names></name>, <name><surname>Linton</surname><given-names>NM</given-names></name>, <name><surname>Akhmetzhanov</surname><given-names>AR</given-names></name>. <article-title>Serial interval of novel coronavirus (COVID-19) infections</article-title>. <source>International Journal of Infectious Diseases</source>. <year>2020</year>;<volume>93</volume>:<fpage>284</fpage>–<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2020.02.060</pub-id><pub-id pub-id-type="pmid">32145466</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>M</given-names></name>, <name><surname>Cook</surname><given-names>AR</given-names></name>, <name><surname>Lim</surname><given-names>JT</given-names></name>, <name><surname>Sun</surname><given-names>Y</given-names></name>, <name><surname>Dickens</surname><given-names>BL</given-names></name>. <article-title>A Systematic Review of COVID-19 Epidemiology Based on Current Evidence</article-title>. <source>Journal of Clinical Medicine</source>. <year>2020</year>;<volume>9</volume>(<issue>4</issue>):<fpage>967</fpage><pub-id pub-id-type="doi">10.3390/jcm9040967</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref042">
                <label>42</label>
                <mixed-citation publication-type="journal"><name><surname>Sanche</surname><given-names>S</given-names></name>, <name><surname>Lin</surname><given-names>YT</given-names></name>, <name><surname>Xu</surname><given-names>C</given-names></name>, <name><surname>Romero-Severson</surname><given-names>E</given-names></name>, <name><surname>Hengartner</surname><given-names>N</given-names></name>, <name><surname>Ke</surname><given-names>R</given-names></name>. <article-title>High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2</article-title>. <source>Emerging Infectious Diseases</source>. <year>2020</year>;<volume>26</volume>(<issue>7</issue>). <pub-id pub-id-type="doi">10.3201/eid2607.200282</pub-id><?supplied-pmid 32255761?><pub-id pub-id-type="pmid">32255761</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref043">
                <label>43</label>
                <mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Gayle</surname><given-names>AA</given-names></name>, <name><surname>Wilder-Smith</surname><given-names>A</given-names></name>, <name><surname>Rocklöv</surname><given-names>J</given-names></name>. <article-title>The reproductive number of COVID-19 is higher compared to SARS coronavirus</article-title>. <source>Journal of Travel Medicine</source>. <year>2020</year>;<volume>27</volume>(<issue>2</issue>):<fpage>1</fpage>–<lpage>4</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref044">
                <label>44</label>
                <mixed-citation publication-type="journal"><name><surname>Stevens</surname><given-names>GA</given-names></name>, <name><surname>Alkema</surname><given-names>L</given-names></name>, <name><surname>Black</surname><given-names>RE</given-names></name>, <name><surname>Boerma</surname><given-names>JT</given-names></name>, <name><surname>Collins</surname><given-names>GS</given-names></name>, <name><surname>Ezzati</surname><given-names>M</given-names></name>, <etal>et al</etal><article-title>Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement</article-title>. <source>PLoS Medicine</source>. <year>2016</year>;<volume>13</volume>(<issue>6</issue>):<fpage>1</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1002056</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref045">
                <label>45</label>
                <mixed-citation publication-type="other">Tsang TK, Wu P, Lin Y, Lau EHY, Leung GM, Benjamin J. Impact of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China; 2020. <pub-id pub-id-type="doi">10.1101/2020.03.23.20041319</pub-id>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref046">
                <label>46</label>
                <mixed-citation publication-type="journal"><name><surname>Fraser</surname><given-names>C</given-names></name>. <article-title>Estimating individual and household reproduction numbers in an emerging epidemic</article-title>. <source>PLoS ONE</source>. <year>2007</year>;<volume>2</volume>(<issue>8</issue>). <pub-id pub-id-type="doi">10.1371/journal.pone.0000758</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244474.ref047">
                <label>47</label>
                <mixed-citation publication-type="journal"><name><surname>MacKinlay</surname><given-names>AC</given-names></name>. <article-title>Event Studies in Economics and Finance</article-title>. <source>Journal of Economic Literature</source>. <year>1997</year>;<volume>35</volume>(<issue>1</issue>):<fpage>13</fpage>–<lpage>39</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref048">
                <label>48</label>
                <mixed-citation publication-type="journal"><name><surname>Farboodi</surname><given-names>M</given-names></name>, <name><surname>Jarosch</surname><given-names>G</given-names></name>, <name><surname>Shimer</surname><given-names>R</given-names></name>. <article-title>Internal and External Effects of Social Distancing in a Pandemic</article-title>. <source>NBER Working Paper</source>. <year>2020</year>;<volume>27059</volume>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref049">
                <label>49</label>
                <mixed-citation publication-type="journal"><name><surname>Guerrieri</surname><given-names>V</given-names></name>, <name><surname>Lorenzoni</surname><given-names>G</given-names></name>, <name><surname>Straub</surname><given-names>L</given-names></name>, <name><surname>Werning</surname><given-names>I</given-names></name>. <article-title>Macroeconomic Implications of COVID-19: Can negative supply shocks cause demand shortages?</article-title><source>NBER Working Paper</source>. <year>2020</year>;<volume>26918</volume>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref050">
                <label>50</label>
                <mixed-citation publication-type="journal"><name><surname>Krüger</surname><given-names>D</given-names></name>, <name><surname>Uhlig</surname><given-names>H</given-names></name>, <name><surname>Xie</surname><given-names>T</given-names></name>. <article-title>Macroeconomic Dynamics and Reallocation in an Epidemic</article-title>. <source>Becker Friedman Institute Working Paper</source>. <year>2020</year>;<fpage>2020</fpage>–<lpage>43</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0244474.ref051">
                <label>51</label>
                <mixed-citation publication-type="other">The New York Times. “Life Has to Go On”: How Sweden Has Faced the Virus Without a Lockdown; 2020. <ext-link ext-link-type="uri" xlink:href="https://www.nytimes.com/2020/04/28/world/europe/sweden-coronavirus-herd-immunity.html">https://www.nytimes.com/2020/04/28/world/europe/sweden-coronavirus-herd-immunity.html</ext-link>.</mixed-citation>
              </ref>
            </ref-list>
          </back>
          <sub-article id="pone.0244474.r001" article-type="aggregated-review-documents">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0244474.r001</article-id>
              <title-group>
                <article-title>Decision Letter 0</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sartorius</surname>
                    <given-names>Benn</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2020 Benn Sartorius</copyright-statement>
                <copyright-year>2020</copyright-year>
                <copyright-holder>Benn Sartorius</copyright-holder>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article id="rel-obj001" ext-link-type="doi" xlink:href="10.1371/journal.pone.0244474" related-article-type="reviewed-article"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>0</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">18 Aug 2020</named-content>
              </p>
              <p>PONE-D-20-13789</p>
              <p>Tracking R of COVID-19: a new real-time estimation using the Kalman filter</p>
              <p>PLOS ONE</p>
              <p>Dear Dr. Kucinskas,</p>
              <p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
              <p>Please submit your revised manuscript by Oct 02 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <email>plosone@plos.org</email>. When you're ready to submit your revision, log on to <ext-link ext-link-type="uri" xlink:href="https://www.editorialmanager.com/pone/">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
              <p>Please include the following items when submitting your revised manuscript:</p>
              <p>
                <list list-type="bullet">
                  <list-item>
                    <p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p>
                  </list-item>
                  <list-item>
                    <p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p>
                  </list-item>
                  <list-item>
                    <p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p>
                  </list-item>
                </list>
              </p>
              <p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
              <p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols">http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link></p>
              <p>We look forward to receiving your revised manuscript.</p>
              <p>Kind regards,</p>
              <p>Benn Sartorius, PhD</p>
              <p>Academic Editor</p>
              <p>PLOS ONE</p>
              <p>Additional Editor Comments:</p>
              <p>The paper proposes a new method for estimating the effective reproduction number of an infectious disease and apply it to track the dynamics of COVID-19 using data from 124 countries. Furthermore they have also used this framework to assess the effectiveness of non-pharmaceutical</p>
              <p>interventions in a sample of 14 European countries. The analysis appears to be very rigorous and the paper well written.</p>
              <p>Comments:</p>
              <p>-Please include a completed GATHER checklist (<ext-link ext-link-type="uri" xlink:href="http://gather-statement.org/">http://gather-statement.org/</ext-link>) and include in your supplementary material as well as make reference to this at the beginning of your methods section.</p>
              <p>-My understanding for COVID-19, is that a SEIR model should be used instead of the SIR. The authors refer to the SEIR formulation in the supplementary as part of their sensitivity analyses but I wonder why the main results were not just based on the SEIR assuming duration of infectiousness based on a published estimates/uncertainty range?</p>
              <p>-Discussion: please include more comparison/contrast with other similar published reproductive number estimates available in the literature.</p>
              <p>Journal requirements:</p>
              <p>When submitting your revision, we need you to address these additional requirements.</p>
              <p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p>
              <p><ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and</p>
              <p>
                <ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link>
              </p>
              <p>2. Thank you for stating the following in the Financial Disclosure section:</p>
              <p>'The author(s) received no specific funding for this work.'</p>
              <p>We note that one or more of the authors are employed by a commercial company: Central Bank of Chile.</p>
              <p>a. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.</p>
              <p>Please also include the following statement within your amended Funding Statement.</p>
              <p>“The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”</p>
              <p>If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement.</p>
              <p>b. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc.  </p>
              <p>Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors <ext-link ext-link-type="uri" xlink:href="about:blank">http://journals.plos.org/plosone/s/competing-interests</ext-link>) . If this adherence statement is not accurate and  there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.</p>
              <p>c. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.</p>
              <p>Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: <ext-link ext-link-type="uri" xlink:href="about:blank">http://journals.plos.org/plosone/s/competing-interests</ext-link></p>
              <p>[Note: HTML markup is below. Please do not edit.]</p>
              <p>Reviewers' comments:</p>
              <p>Reviewer's Responses to Questions</p>
              <p>
                <bold>Comments to the Author</bold>
              </p>
              <p>1. Is the manuscript technically sound, and do the data support the conclusions?</p>
              <p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p>
              <p>Reviewer #1: Partly</p>
              <p>**********</p>
              <p>2. Has the statistical analysis been performed appropriately and rigorously? </p>
              <p>Reviewer #1: Yes</p>
              <p>**********</p>
              <p>3. Have the authors made all data underlying the findings in their manuscript fully available?</p>
              <p>The <ext-link ext-link-type="uri" xlink:href="http://www.plosone.org/static/policies.action#sharing">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
              <p>Reviewer #1: Yes</p>
              <p>**********</p>
              <p>4. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
              <p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
              <p>Reviewer #1: Yes</p>
              <p>**********</p>
              <p>5. Review Comments to the Author</p>
              <p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p>
              <p>Reviewer #1: Comments to the authors</p>
              <p>This manuscript is a useful addition to primary research on estimating the effective reproduction number of infectious diseases, applied to the ongoing COVID-19 pandemic. The method presented is said to produce estimates of both the instantaneous and cohort/case reproduction number which is advantageous. The conclusions drawn from applying the method to COVID-19 are in the most part sound and well explained though some important minor changes and clarifications around the effect of lockdown are advised below.</p>
              <p>Detailed feedback:</p>
              <p>Abstract</p>
              <p>“the method is very easy to apply in practice” –consider being more specific about what makes it easy to apply</p>
              <p>Main text</p>
              <p>Repeated throughout - when referencing material in the SI, the authors should include the section number and figure number to help the reader quickly locate the material.</p>
              <p>Line 2. At the beginning the authors should stress the difference between R0 and effective reproduction number and include references for standard definitions. This difference is highlighted in Lines 82 through 84. However, it would be better to move this up in the introduction to give a better background.</p>
              <p>Lines 36 to 39. References that support each of the approaches outlined should be cited here.</p>
              <p>Line 60. It would be good to be more specific/formal about what is meant by “well-behaved estimates”</p>
              <p>Lines 112. "As is well known, the local-level model is sufficiently flexible to capture rich dynamic patterns in the data." The authors should give some references here to support this assertion to help readers.</p>
              <p>Line 160. A sentence about the sensitivity of your results to your chosen serial would be good here to summarise what you show in the supplementary (particularly as you note show in the SI that having an accurate estimate for the this parameter is required for your estimator to be robust to model misspecifications)</p>
              <p>Line 168 &amp; Figure 1. Is it meaningful to present Rt for the whole world aggregated together? Might be better to present more of your country level estimates.</p>
              <p>Figure 2. Since different colours are used to denote Rt estimates for China, Italy and the US, there is no need to also use different linetypes.</p>
              <p>Line 181. Add reference to the Figure number in the SI.</p>
              <p>Line 187. "..but at a slower rate than previously observed in China". Can the authors quantify this rate? For example, the time difference between the start of the epidemic (as defined in this paper) and the first time point estimate of R is below 1?</p>
              <p>Line 195. The statement will be strengthened if the authors provide the estimate with confidence bounds. A similar comment applies when qualitative statements are made e.g., "somewhat", "almost" etc.</p>
              <p>Line 208. Add reference to the exact section number and figure that the reader should check.</p>
              <p>Line 236. "Event study analysis" I do not think that this is a commonly used terminology in epidemiology, and the authors should provide a brief definition to help the reader.</p>
              <p>Line 238. Present 95% confidence intervals alongside these point estimates.</p>
              <p>Line 239. "There is no visually detectible break in the slope of R around the introduction of lockdown". Can the authors quantify what they mean by "around the time of lockdown"? Any change in policy or behaviour is not expected to have an immediate effect on R, and this should be taken into consideration. This comment also applies to Line 247 where the authors state that "R_t appears to be unaffected by lockdown." Consider rephrasing this. No counterfactual is available, and just because behaviour changed before lockdown doesn’t mean it would have remained changed in the absence of a lockdown as you later mention. In addition, peoples initial behavioural change may have been influenced by discourse around potential upcoming lockdown and lockdowns introduced in other countries prior to introduction in their own country.</p>
              <p>Line 247. A brief description of the construction of the mobility index should be included in the main text. Can the authors check also that the decline in mobility before lockdown is consistent across all countries considered, and for other combinations e.g. countries in Asia vs countries in Europe? Finally, my comment about qualitative statements is applicable to the description in SI ("the first principal component explains a little less than 85% of the total variance in the data"). Perhaps state the actual variance explained?</p>
              <p>Line 266. State what is u_{i, t}.</p>
              <p>Line 276. The only reason Rt can fall is because of... omit "why"</p>
              <p>Table 2. If you could add concise titles to the columns in place of (1) to (4) it would be more immediately clear to the reader.</p>
              <p>Line 312. Give a brief definition/detail on what is meant by endogeneity problems or use a different phrase – it is not guaranteed to be terminology that readers will have come across, though they will be familiar with the problem itself.</p>
              <p>Supplementary material</p>
              <p>Page 1 sentence one “also obtains” should be “is also obtained”</p>
              <p>SI Section 6 page 8. This section is very interesting – inconsistent levels of reporting is a major issue in Rt estimation. I would make sure readers are clearly signposted to this section from the main text when you talk about data problems there.</p>
              <p>SI page 18. "For both validation exercises performed in the present section, we include all countries for which we have at least 20 observations after the onset of the epidemic (100 cumulative cases of COVID-19 reached)." Can the authors state how many countries were included? Figure 4 states N =13, but I believe this means only the European countries considered minus one?</p>
              <p>**********</p>
              <p>6. PLOS authors have the option to publish the peer review history of their article (<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
              <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
              <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link ext-link-type="uri" xlink:href="https://www.plos.org/privacy-policy">Privacy Policy</ext-link>.</p>
              <p>Reviewer #1: No</p>
              <p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
              <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link ext-link-type="uri" xlink:href="https://pacev2.apexcovantage.com/">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p>
            </body>
          </sub-article>
          <sub-article id="pone.0244474.r002" article-type="author-comment">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0244474.r002</article-id>
              <title-group>
                <article-title>Author response to Decision Letter 0</article-title>
              </title-group>
              <related-article id="rel-obj002" ext-link-type="doi" xlink:href="10.1371/journal.pone.0244474" related-article-type="editor-report"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>1</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="author-response-date">16 Nov 2020</named-content>
              </p>
              <p>Dear Editor,</p>
              <p>We would like to sincerely thank you for the opportunity to revise our manuscript entitled “Tracking R of COVID-19: A New Real-Time Estimation Using the Kalman Filter.” In addition, we are grateful to the Referee for their insightful and constructive suggestions on how to improve the paper.</p>
              <p>All comments raised by you and the Referee have been addressed in the revised manuscript. Most suggestions have been incorporated in the main body, while a few are addressed in the Supplementary Appendix to avoid overextending the main paper.</p>
              <p>To avoid any possible misunderstanding, we would like to clarify that the Central Bank of Chile is a public institution owned and supervised by the Chilean government.</p>
              <p>Point-by-point responses are provided in the attached files.</p>
              <p>Dr. Francisco Arroyo-Marioli</p>
              <p>Francisco Bullano,</p>
              <p>Dr. Simas Kučinskas,</p>
              <p>Dr. Carlos Rondón-Moreno</p>
              <supplementary-material content-type="local-data" id="pone.0244474.s003">
                <label>Attachment</label>
                <caption>
                  <p>Submitted filename: <named-content content-type="submitted-filename">response_to_Reviewer.pdf</named-content></p>
                </caption>
                <media xlink:href="pone.0244474.s003.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </body>
          </sub-article>
          <sub-article id="pone.0244474.r003" article-type="editor-report">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0244474.r003</article-id>
              <title-group>
                <article-title>Decision Letter 1</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sartorius</surname>
                    <given-names>Benn</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2020 Benn Sartorius</copyright-statement>
                <copyright-year>2020</copyright-year>
                <copyright-holder>Benn Sartorius</copyright-holder>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article id="rel-obj003" ext-link-type="doi" xlink:href="10.1371/journal.pone.0244474" related-article-type="reviewed-article"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>1</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">11 Dec 2020</named-content>
              </p>
              <p>Tracking R of COVID-19: a new real-time estimation using the Kalman filter</p>
              <p>PONE-D-20-13789R1</p>
              <p>Dear Dr. Kucinskas,</p>
              <p>We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p>
              <p>Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p>
              <p>An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <ext-link ext-link-type="uri" xlink:href="http://www.editorialmanager.com/pone/">http://www.editorialmanager.com/pone/</ext-link>, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <email>authorbilling@plos.org</email>.</p>
              <p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email>onepress@plos.org</email>.</p>
              <p>Kind regards,</p>
              <p>Benn Sartorius, PhD</p>
              <p>Academic Editor</p>
              <p>PLOS ONE</p>
              <p>Additional Editor Comments (optional):</p>
              <p>Reviewers' comments:</p>
            </body>
          </sub-article>
          <sub-article id="pone.0244474.r004" article-type="editor-report">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0244474.r004</article-id>
              <title-group>
                <article-title>Acceptance letter</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sartorius</surname>
                    <given-names>Benn</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2020 Benn Sartorius</copyright-statement>
                <copyright-year>2020</copyright-year>
                <copyright-holder>Benn Sartorius</copyright-holder>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article id="rel-obj004" ext-link-type="doi" xlink:href="10.1371/journal.pone.0244474" related-article-type="reviewed-article"/>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">22 Dec 2020</named-content>
              </p>
              <p>PONE-D-20-13789R1</p>
              <p>Tracking <italic>R</italic> of COVID-19: a new real-time estimation using the Kalman filter</p>
              <p>Dear Dr. Kucinskas:</p>
              <p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.</p>
              <p>If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <email>onepress@plos.org</email>.</p>
              <p>If we can help with anything else, please email us at <email>plosone@plos.org</email>.</p>
              <p>Thank you for submitting your work to PLOS ONE and supporting open access.</p>
              <p>Kind regards,</p>
              <p>PLOS ONE Editorial Office Staff</p>
              <p>on behalf of</p>
              <p>Dr. Benn Sartorius</p>
              <p>Academic Editor</p>
              <p>PLOS ONE</p>
            </body>
          </sub-article>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
